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DETERMINING THE CELLULAR BASIS OF 
 
TRANSCRANIAL BRAIN STIMULATION IN MITIGATING 
 
THE EFFECTS OF ISCHEMIC BRAIN INJURY 
 
PATRICK McGILLEN  
 
ABSTRACT  
Focal ischemic stroke causes an alteration of the excitation – inhibition balance in 
neurons around the infarct, and in distant areas connected to the damaged region.  These 
widespread changes contribute to symptomatology and reduce activity in areas that have 
the capacity to functionally compensate for the effect of lesion.  The ability to control 
excitability in specific brain areas after stroke could restore normal excitability and 
promote functional recovery.  Non-invasive brain stimulation techniques have the 
potential to produce targeted change in excitability in neural tissue.  One such technique, 
transcranial direct current stimulation (tDCS), modulates cortical excitability in a lasting, 
polarity-specific manner.  The hypotheses of this study were that 1) focal unilateral 
ischemic damage to the parietal cortex would produce repeatable alterations in the 
inhibitory network in ipsilateral and contralateral brain areas, and 2) tDCS applied after 
the ischemia would alter the size of the stroke and change the inhibitory networks. 
A unilateral non-invasive photothrombic stroke was produced under isoflurane 
anesthesia, and cathodal (n=5), anodal (n=5), or sham (n=6) tDCS (5 minutes, 10.0mA) 
was subsequently administered to the site.  Four additional animals were assigned to 
sham operation groups that did not undergo photothrombosis. Animals recovered for 24 
hours, after which their brains were cut, and prepared for single- and double-labeled 
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immunocytochemistry to analyze the functional activity of excitatory neurons and 
inhibitory interneurons, astrogliosis, and neuronal degeneration.  
Results demonstrate that unilateral ischemic injury does not produce a 
hyperexcitability of the contralateral cortex or otherwise alter the activation status of 
immunohistochemcially-defined inhibitory or disinhibitory neurons, a finding discrepant 
with the rationale used to treat ischemic injury in humans.  Similar findings were 
identified in the ipsilateral cortex.  Results did show that ischemia activated white matter 
neurons, as well as neurons in layer III ipsilateral to the lesion extending 1–2mm into the 
intact cortex. Staining for neuronal degeneration revealed clusters of pyramidal-shape 
neurons in layer V neurons extending quite far from the lesion.  Addition of cathodal, but 
not anodal tDCS produced an overall decrease in the lesion size, but this decrease was not 
statistically reliable.  Stimulation also did not obviously alter the activation status of 
inhibitory or disinhibitory neurons.  Stimulation of both types prevented the appearance 
of cell death markers in layer V, and anodal tDCS reduced the activation of excitatory 
layer III neurons.  
These data illustrate the utility of using tDCS during the production of a lesion to 
mitigating the size and impact of lesion.  The data also sheds doubt on the rationale for 
applying brain stimulation to the contralesional cortex to treat stroke, at least in the acute 
stage.  Finally, the data illustrate the extent to which the lesion affects widespread and 
specific neural circuits, and highlights the potential use of tDCS in manipulating the 
activity of these circuits. 
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INTRODUCTION 
 
1.1 The incidence and burden of stroke 
Stroke is a leading cause of death and disability in the United States (US) and 
abroad. In 2010, the global prevalence of stroke was 33 million cases. Stroke accounted 
for 6.45 million deaths or 11.8% of total deaths worldwide in 2013, making it the third 
leading cause of global deaths behind ischemic heart disease and lower respiratory 
infections (GBD 2013 Mortality and Causes of Death Collaborators, 2015).  
Although the incidence of stroke has decreased in recent decades in the United 
States, it remains the fifth-leading cause of death in the US as of 2013 and is a leading 
cause of disability according to 2014 report by the American Heart Association (AHA). 
In 2011, approximately 795,000 Americans experienced a new or recurrent stroke 
meaning that someone in the US experiences a stroke every 40 seconds (Mozaffarian et 
al., 2015). Of these cases, stroke killed nearly 130,000 people (Mozaffarian et al., 2015). 
 
1.2 The cost of stroke in the US 
The care of patients with stroke represents a significant proportion of US national 
healthcare expenditures. In 2011 the estimated direct medical cost of stroke in the US 
was $17.5 billion (Mozaffarian et al., 2015). Direct spending on non–nursing home stroke 
care accounted for greater than 10.7% of the Medicare budget and more than 1.7% of 
overall national health expenditures in 2012 (Ovbiagele et al., 2013). As the US 
population continues to increase in number, and since approximately two-thirds of all 
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strokes occurring in those older than 65 years, current economic forecasts project that the 
$71.55 billion in real (2010$) total direct medical costs attributed to stroke will triple to 
$184.13 billion by 2030 (Table 1).  
Given the growing demographic and economic challenges attributable to the 
incidence of stroke in the US, advancements in the prevention and acute treatment of 
stroke are duly warranted as a matter of improving both healthcare outcomes and 
controlling stroke-related costs burdens. 
 
Table 1. Projected Direct (Medical) Costs of Stroke, 2012–2030, in the United States. 
Between 2012 and 2013 the direct medical costs of stroke are expected to rise significantly across 
all demographic age groups in the US, representing an overall relative 157% rise in total 
expenditures during the time period. Adapted from Ovbiagele et al., 2013. 
Demographic 
Group 
Cost, Billions 2010$ 
% Relative Change 
(2012–2030) 
2012 2015 2020 2025 2030 
Age, y 
     
  
 18–44 1.14 1.25 1.48 1.75 2.05 79.8 
 45–64 12.99 14.45 16.85 19.36 22.69 74.7 
 65–79 31.66 38.82 53.59 71.75 89.35 182.2 
 ≥80 25.76 28.76 35.65 47.91 70.04 171.9 
Overall 71.55 83.28 107.57 140.77 184.13 157.3 
 
 
1.3 The biology of stroke 
Compared with other tissues, the brain consumes a disproportionate amount of 
oxygen and glucose. The brain consumes 20% of total body oxygen consumption yet it 
represents at most 2% of body mass (Aster et al., 2013). In order to meets these high 
energy demands, the circulatory system directs a substantial proportion of the cardiac 
output to the brain; cerebral blood flow represent 15% of the resting cardiac output and 
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various autoregulatory mechanisms exists to ensure that the delivery of blood to the brain 
remains continuous (Aster et al. 2013).  The brain receives so much of the cardiac output 
because the component cells of the brain, the neurons, rely on a continuous supply of 
oxygen and nutrients.  A stroke is a medical emergency that represents an acute 
interruption of cerebral blood flow, either by ischemia (vessel occlusion) or hemorrhage 
(intracerebral bleeding).  The interruption of nutrients and oxygen causes neurons to 
begin to die within minutes (Lipton, 1999). 
Cerebral tissue death as a result of stroke can be either global or focal in nature, 
depending on the underlying pathologic mechanism and severity of the cerebrovascular 
interruption. The associated symptoms and clinical presentations of a stroke likewise vary 
with the severity and location of ischemic injury, ranging from deficits such as speech 
difficulties to more widespread manifestations such as paralysis. In general, the death of a 
circumscribed brain region produces functional deficits tied to the normal function of the 
affected brain area. These deficits are typically profound and patients rarely make a full 
recovery. In most strokes, there is a region of neural tissue that is intractably lost with 
stroke.  This is called the core.  Surrounding the core is an area where cerebral ischemia 
is incomplete and blood flow remains above 20% of normal.  In this region, called the 
penumbra (meaning – shadow), neurons are alive, but vulnerable to cell death. It is in this 
region where neurons can either die or recover (Aminoff et al., 2015). Survival of cells 
within the penumbra is time-dependent, with an increased in elapsed time since stroke 
onset correlating with a decrease in penumbra volume that escapes infarction (Guadagno 
et al., 2003).  
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1.4 Stroke prognosis and Current Acute Stroke Therapies 
 The nature and severity of the neurologic deficit associated with the stroke is one 
of the most important predictors of short and long-term outcome (Aminoff et al., 2015). 
Less than 80% of all patients with stroke survive beyond one month of incidence and 10-
year survival rates of patients with stroke have been approximated at 35% (Aminoff et 
al., 2015). Clinical observations have shown more favorable long-term prognosis and 
spontaneous neurological recovery in stroke patients are highly correlated with the 
survival of penumbral tissue (Guadagno et al., 2003). Thus, early interventions aimed at 
extending the cell survival rates within this at-risk tissue. The primary intervention used 
to increase survival of penumbra neurons is to quickly recover the flow of blood to the 
deprived tissue.  This occurs through two mechanisms.  The first is the use of intravenous 
thrombolysis whereby the dissolution of a blood clot (thrombus) is caused by the infusion 
of a pharmacological agent into the blood, such as tissue plasminogen activator (tPA). 
The second is endovascular treatment, an invasive procedure that recanalizes occlusions 
in large intracranial arteries in patients suffering from acute ischemic stroke (Broderick et 
al., 2015). The combination of the endovascular therapy and thrombolysis is also used 
(Woodruff et al., 2011). These techniques have demonstrated promising rates of 
decreased morbidity and mortality following stroke (Murray et al., 2010; Campbell et al., 
2015; Goyal et al., 2015; Jovin et al., 2015). However, these interventions have 
shortcomings. In both cases reperfusion injury, the maladaptive immune response to re-
oxygenation after the restoration of blood flow to hypoxic tissue, is a potential concern, 
as the processes are known to elicit an inflammatory response that causes additional 
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injury to the microcirculation and brain tissue of the perilesional areas (Arumugam et al., 
2005). Furthermore, the delivery of these interventions requires time-consuming in-
hospital clinical examinations, tests, and operations. Thus, the development of an even 
more immediate, non-invasive pre-hospital care therapy to complement the reperfusion of 
ischemic brain is needed. 
 
1.5 Ischemic Stroke Pathophysiology 
Ischemia is a reduction in blood flow that alters normal cellular function and that 
initiates a series of events that culminates in neuronal damage and cellular death.  
Ischemic stroke is understood as a heterogeneous but interrelated process resulting from 
the interruption of cerebral blood flow.  Once deprived of oxygen and glucose, glucose-
dependent ATP production falls dramatically and energy-dependent cellular pumps fail to 
maintain or restore intracellular ionic gradients. Intracellular sodium levels rise and 
potassium flows out of the cell into the extracellular space causing neuronal 
depolarization. Cell swelling ensues due to osmosis. As a result of the depolarization, 
extracellular levels of glutamate, the brain’s chief excitatory neurotransmitter, rise 
dramatically and produce widespread activation of N-methyl-D-aspartate receptors 
(NMDA-R) (Martin & Wang, 2010) and subsequent calcium entry to neurons through 
voltage-dependent and ligand-gated ion channels. The flood of calcium into the cell 
begins a series of intrinsic neuroprotective responses to ischemia-induction to severe cell 
stress as well as multiple intrinsic signaling pathways that contribute to neuronal death 
after stroke (Martin & Wang, 2010). In this way a significant portion of ischemia-induced 
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neuronal damage is mediated by excitotoxic increases in intracellular calcium (Mehta et 
al., 2007).  Ultimately, whether neurons escape cell death pathways or succumb to them, 
is heavily influenced by subsequent ischemia-induced excitotoxic changes in the tissue 
microenvironments. 
Shifting the balance of these opposing intrinsic cell stress pathways towards cell 
death are other factors associated with ischemia: namely, a rise in free radical formation, 
astrogliosis, an increase in leukocyte infiltration and a breakdown of the blood brain 
barrier. In addition to damaging cell membranes, mitochondria and DNA, free radicals 
such as superoxide anion radical, hydroxyl radical, nitric oxide and other reactive other 
species (ROS), are thought to stimulate the intrinsic pathways of cell death following 
stroke (Allen & Bayraktutan, 2009). Furthermore, free radicals promote the formation of 
pro-inflammatory molecules such as caspase 1, which in turn activate glial cells, 
endothelial cells, attract leukocytes to the site of ischemia, and contribute to blood-brain 
barrier (BBB) dysfunction (Allen & Bayraktutan, 2009; Kim et al., 2014). Evidence 
suggests that the accumulation and activation of leukocytes in the brain up to 48 hours 
after stroke, particularly neutrophils, plays a role in the evolution of ischemic injury as 
rodents with fewer circulating neutrophils show reduced infarct volumes and improved 
neurological outcomes following stroke (Hudome et al., 1997). Blood brain barrier 
(BBB) dysfunction, marked by increased permeability and diminished barrier function, 
and degradation of the basal lamina of the brain endothelium, is also observed in 
response to the pro-inflammatory conditions induced by ischemic injury in the brain (del 
Zoppo & Hallenbeck, 2000). 
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During the subacute phase of ischemic brain injury, the first 1 to 7 days after the 
onset of ischemia, astrocytes accumulate around the site of injury and transform in a 
process known as astrogliosis into a reactive phenotype marked a dramatic increase in 
cell size and expression of cytoskeletal proteins, such as glial acidic fibrillary protein 
(GFAP) and vimentin (Patience et al., 2015). Astrogliosis is thought to mediate the 
production of a barrier composed of extracellular matrix proteins around the infarct core 
termed the glial scar. However, activation of astrocytes in the peri-infarct area and the 
occurrence of delayed infarct expansion in rat models of permanent focal ischemia have 
shown to be closely related in previous studies (Matsui et al., 2002; Mori et al., 2005; 
Ding et al., 2009). The astrocytic intracellular calcium binding protein S100B is 
overexpressed during astrogliosis and plays a pivotal pathological role after ischemia by 
upregulating the synthesis of inflammatory mediators, such as NO and TNF-alpha, that 
cause further oxidative stress and neuronal apoptosis. Previous studies have also shown 
that the up-regulation and synthesis of S100B by activated astrocytes in the peri-infarct 
area beginning 1 day after ischemia are positively associated with the severity of delayed 
infarct expansion in rodent models of middle cerebral artery occlusion (MCAO) (Mori et 
al., 2008; Mori et al., 2010). 
In conjunction with the pathophysiological changes induced by cellular energy 
failure and excitotoxicity, the inflammatory and glial responses to ischemia represent a 
detrimental influence on stroke outcomes and indicate that cellular self-harm processes 
exist within the brain itself (Woodruff et al., 2011). These complex and interrelated 
ischemia-induced pathophysiologic changes to the brain under conditions of ischemia 
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provide numerous pathways by which therapeutic interventions can be developed to 
reduce or prevent the tendency of the brain to exacerbate ischemic injury (Woodruff et 
al., 2011).  
1.5.1 The ischemic core and the ischemic penumbra 
As indicated above, the tissue affected by stroke can be differentiated into the 
core and penumbra.  These regions are not only differentiated based on likelihood of cell 
death, but also on differences in biochemical and pathophysiologic responses (Woodruff 
et al., 2011). The two types of ischemic tissue exhibit differences in metabolism and in 
susceptibilities to neuroprotectants, and it is likely that the death of neurons in each 
compartment occurs in different ways and via different mechanisms. The ischemic core 
represents lethally injured tissue (Woodruff et al., 2011). Within 1 to 3 minutes of 
ischemic insult, intracellular adenosine triphosphate (ATP) levels fall to approximately 
25% of basal levels sparking a rapid, permanent anoxic depolarization (Lipton, 1999). 
These core cells then undergo abrupt necrotic cell death characterized by cellular and 
organelle swelling followed by catastrophic destruction of nuclear, organelle, and cell 
membrane structure. As a result, necrotic cells indiscriminately spill their cellular 
contents into the extracellular space (Majno & Joris, 1995). 
The penumbra, also known as the per-infarct zone, is functionally silent, and is 
subjected to a less severe and more slowly evolving ischemia. Like the cells of the 
ischemic core, those of the penumbra are subject to the deleterious events of 
excitotoxicity, oxidative DNA damage and gliosis that lead to infarct (Lipton, 1999). The 
penumbra does not undergo anoxic depolarization with concurrent ion changes during the 
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ischemia because ATP levels are maintained at 50–70% of normal during ischemia 
(Lipton, 1999). By 3.5 hours after the start of the ischemia, there is significant 
compromise of cell function in the penumbra.  There is a fall in glucose utilization to 
approximately 50% of normal levels, the electroencephalogram is silenced and evoked 
neuronal transmission is reduced. The neurons of the penumbra do undergo 
depolarizations but they are transient in nature and are dependent on both NMDA-
glutamate receptors as well as non-NMDA-glutamate receptors (Lipton, 1999). These 
“peri-infarct depolarizations” (PIDs) are a pathophysiological phenomenon akin to 
cortical spreading depression (CSD) in that spontaneous waves of neuronal excitations 
followed by prolonged hyperpolarization propagate from the electrically unstable peri-
infarct tissue (Ayata & Lauritzen, 2015). 
In contrast to the neurons of ischemic core, those in the penumbra region retain 
their metabolic activity (Broughton et al., 2009), though it is significantly attenuated (W. 
Dalton Dietrich, 1986).  The preservation of metabolic activity is thought to confer a 
potential protection against immediate cell death. However, it is more accurate to say that 
neurons of the penumbra undergo delayed apoptosis or autophagocytotic cell death, 
which delays recruitment into the ischemic core for several hours or days (Katsman et al., 
2003; Woodruff et al., 2011). Unlike the necrotic cell death that occurs in the core of an 
ischemic lesion, apoptosis is a form of programmed cell death that is orderly – this 
process avoids disruption and damage of neighboring cells, and is highly ATP-dependent. 
Morphologically, cells undergoing apoptosis shrink into dense bodies that exhibit dense 
pyknotic chromatin and exhibit dissolution of the nucleus (karyorhexis). As the process 
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continues, pyknotic nuclear fragments known as apoptotic bodies, bud from the 
condensing cell and can be subsequently phagocytized by mononuclear phagocytes or 
neighboring cells during the ensuing 2 to 3 weeks (Majno & Joris, 1995; et al., 2012). 
The delayed cell death in the penumbra provides a window of opportunity for 
therapeutic interventions aimed at rescuing the at-risk penumbra tissue and limiting the 
expansion of the core region (Legos & Barone, 2003).  However, the physiological 
conditions and cellular mechanisms by which neurons of penumbra avoid or succumb to 
ischemia induced cell death are not fully understood. Elucidating these conditions and 
mechanisms are therefore, important to mount effective therapies that tilt the balance 
away from lesion expansion and poorer functional outcomes. 
1.5.2 The importance of diaschisis and disinhibition in pathology and disease 
The effects of focal ischemia are not limited to the infarcted core and penumbra 
regions of the brain.  The neurons affected by ischemia extend axons to other regions of 
the brain, and therefore changes in the excitability of these neurons may translate to 
functional changes in connected brain areas.  Regions connected to the damaged area are 
affected with a magnitude proportional to the strength of the functional dependence. 
These remote changes were first implicated in the pathophysiology of focal brain 
ischemia in 1914 by von Monakow who attributed previously unexplained clinical 
deficits to functional changes in structurally intact but neuroanatomically connected 
regions of the brain distant to the site of the lesion (von Monakow, 1914 cf. Witte et al., 
2000). Dubbed by Von Monakow as “diaschisis”, these long-range functional changes in 
brain activity have garnered extensive clinical interest.  
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Diaschisis can be either focal or non-focal in nature.  Based on von Monakow’s 
classical description of diaschisis, focal diaschisis encompasses the alterations in 
neuronal metabolism and/or excitability of anatomically preserved brain regions that are 
distant from the original site of brain injury (von Monakow, 1914 cf. Feeney & Baron, 
1986). Focal diaschisis can be further delineated into diaschisis at rest and functional 
diaschisis.  Carrera and Tononi define the former as focal decrease in energy metabolism 
at rest without stimulation or activation, in remote but anatomically intact brain regions 
(Carrera & Tononi, 2014). Diaschisis at rest can be further categorized based on whether 
the uninjured hemisphere is affected. Such cases are referred to as cortico-cortical 
diaschisis, and abnormalities in metabolism of the uninjured are observed due to 
interrupted transhemispheric pathways, such as the neuronal pathways of the corpus 
callosum or thalamus (Carrera & Tononi, 2014). This phenomena was demonstrated in 
rat models in which stroke induced lesion of the cortex were found to produce 
hypometabolism in the injured cortex coupled with reduction in neuronal spiking activity 
in the uninjured cortex (layer III-V) and cerebellum at rest (Gold & Lauritzen, 2002; 
Enager et al., 2004). 
The term functional diaschisis is restricted to dysfunctions in the metabolism or 
neuronal activity of remote, anatomically intact brain regions in response to activations 
and stimulations (Carrera & Tononi, 2014). Functional diaschisis has been reported by 
multiple studies that have demonstrated an increase in amplitude of somatosensory 
evoked potentials in the contralesional cortex of brains damaged by focal lesions (Obeso 
et al., 1980; Carrera & Tononi, 2014). Within minutes of the onset of focal ischemia in 
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rodents, there is increase in remote excitability that is secondary to a net reduction in the 
strength of inhibitory networks of the lesioned hemisphere and the strengthening of 
excitatory synaptic transmission in perilesional tissue. Utilizing various extracellular 
paired-pulse stimulation paradigms in rodents, investigators have shown a reduced 
efficacy of the brain’s inhibitory networks in both perilesional and remote brain areas 
following focal ischemic stroke (Buchkremer-Ratzmann et al., 1996, Buchkremer-
Ratzmann and Witte, 1997, Farkas et al., 2003 and Reinecke et al., 1999). The net 
reduction in the brain’s inhibitory system has been shown to lead to a subsequent increase 
in the spontaneous activity of the perilesional excitatory neurons in rats that appears 
twenty-four after the induction of a photothrombic lesion and lasts up to three months 
(Schiene et al., 1996).  Furthermore, intracellular recordings and autoradiographical 
techniques have demonstrated that the increased cortical excitability of perilesional tissue 
is accompanied by a long-lasting reduction of GABAA-dependent inhibition (Neumann-
Haefelin et al., 1995; Zilles et al., 1999; Schiene et al., 1996; Qu et al., 1998; Que et al., 
1999).  
Non-focal diaschisis refers to the alterations in a distinct brain network’s strength 
and direction as result of lost afferent input, which in the case of stroke is the loss of 
afferent from the lesioned tissue. Also known as connectional diaschisis (Campo et al., 
2012), the resultant changes in network activity and metabolism are similar to those of 
focal diaschisis. In both cases the effects are most pronounced immediately after stroke, 
are strongly associated with functional impairment, and are shown to normalize over time 
and recovery (Carrera & Tononi, 2014). However, whereas its focal counterpart focuses 
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on the neurophysiological abnormalities circumscribed remote regions directly coupled to 
the site of injury, non-focal diaschisis is concerned with the alterations in connectivity 
between remote networks not necessarily directly coupled to the site of injury. He et al. 
demonstrated with functional MRI, that acute focal stroke in right ventral parietal cortex 
in 11 patients disrupted both the interhemispheric functional connectivity of an attention 
network within the injury site as well as a completely separate attention network in the 
dorsal posterior parietal cortex (He et al., 2007). Eventually, the disruptions in 
interhemispheric functional connectivity of the dorsal parietal cortex attention network 
were found to fully resolve but attention network of the directly injured ventral parietal 
cortex did remained permanently disrupted.  
Taken together, these studies suggest that the resultant imbalance of inhibitory 
and excitatory systems of the perilesional and remote projection areas in the brain, 
whether the result of focal or non-focal diaschisis, act as potential sources of neuronal 
excitotoxicity, irreversible cellular dysfunction and cell death in the penumbra following 
focal ischemia (Luhmann, 1996).  Alternatively, the diaschisis may unduly influence and 
reduce the activity of inhibitory circuits, causing a release of activity in the contralateral 
regions. In either case inhibitory interneurons involved in direct inhibition of pyramidal 
neurons as well as those involved in disinhibition of cortical circuits, are hypothesized to 
play a contributing role.  Importantly, however, there are no studies of the cellular basis 
of the dysfunction of inhibitory neurons after stroke and ischemia. Regardless of the 
source of electrical imbalance, defining the exact cellular basis of diaschisis in 
exacerbating cerebral injury after stroke has proven extremely difficult. PIDs, 
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astrogliosis, and inflammation after stroke may also contribute to the observed changes in 
network excitability and inhibition, confounding the exact role of diaschisis (Mohajerani 
et al., 2011). Moreover, the brain’s intrinsic mechanisms of recovery, such as plasticity 
and vicariation (the redundancy of brain regions whereby one part of the brain is able to 
substitute function for another), commence immediately following stroke, and thus, 
clouding the exact effects of diaschisis. 
 
1.6 Transcranial direct current stimulation to restore balance in cortical 
connectivity 
With growing clinical interest in diaschisis, restoring balance in excitatory and 
inhibitory networks within and between hemispheres immediately after stroke has 
become a target for neuromodulation. Attenuating or preventing contralesional over-
activation early after stroke is thought to promote recovery in the brain, as a shift towards 
a balanced activation between hemispheres over time is correlated with improved 
recovery (Tecchio et al., 2007; Carrera & Tononi, 2014). Thus far, transcranial magnetic 
stimulation (TMS) and transcranial direct current stimulation (tDCS) have emerged as 
promising strategies for normalizing the abnormalities in neural activity due to diaschisis 
(Nowak et al., 2008; Ameli et al., 2009; Grefkes & Fink, 2012; Sharma & Cohen, 2012). 
In addition to being relatively inexpensive and non-invasive, both TMS and tDCS have 
the potential to modulate local cortical excitability in a long-lasting manner.  
In addition to their effects on the functional abnormalities caused by diaschisis, it 
has been proposed that under the right conditions, brain stimulation can reduce the extent 
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of cerebral injury during a critical period after stroke onset. Restoring the balance 
between inhibitory and excitatory networks of brain following focal ischemic stroke may 
provide new approaches towards early prevention of the expansion of ischemic core to 
intact brain tissue of the penumbra and thus, reducing long-term neurological deficits. 
Previous clinical approaches with calcium and N-methyl-D-aspartate channel (NMDA) 
antagonists targeted at alleviating the reduction in the brain’s net inhibitory function 
following focal ischemic stroke have fallen short in this regard (Annunziato, 2010). 
However, there is a rapidly growing interest in the use of noninvasive brain stimulation to 
alter excitability levels as a means of attenuating dysfunctional excitatory and inhibitory 
systems that potentially contribute to the early excitotoxic damage observed in stroke. 
Preliminary research suggests that this could be achieved with the application of low-
intensity tDCS therapies, which have been shown to lasting effects on cortical neuron 
excitability and activity (Liebetanz et al., 2009). 
tDCS therapies involve the application of direct anodal or cathodal currents via 
surface electrodes as a means of modifying the transmembrane neuronal potential (Priori 
et al., 1998; Nitsche et al., 2008). Nitsche et al. observed polarity-dependent shifts in 
cortical excitability of the primary motor cortex following tDCS application (Nitsche et 
al., 2003b; Nitsche et al., 2008). Anodal-tDCS (A-tDCS) was shown to have a 
depolarizing effect that enhanced corticomotor excitability and cathodal-tDCS (C-tDCS) 
was shown to exert a hyperpolarizing effect leading to a reduction of corticomotor 
excitability in humans (Nitsche and Paulus, 2000; Nitsche and Paulus, 2001). Prior 
animal studies had shown that the consistency of these excitability shifts is determined by 
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stimulation duration and current intensity (Bindman et al., 1962; Creutzfeldt et al., 1962; 
Landau et al., 1963; Purpura and McMurtry, 1965).  
 Recognizing the ability of tDCS to modulate cortical activity in these ways has 
led to its application in the post-stroke setting as a means of enhancing synaptic plasticity 
to improve chronic motor impairment by offsetting the functional imbalance between the 
lesioned and intact hemispheres (Schlaug et al., 2008). More recent work with rats aimed 
to investigate tDCS’s neuroprotective efficacy in the acute phase of stroke, demonstrated 
measurable reductions in final infarct volume compared to controls when C-tDCS is 
applied to the affected hemisphere during MCAO (Peruzzotti-Jametti et al., 2013; 
Notturno et al., 2014). TDCS may reduce infarct volume by reducing release of cortical 
glutamate, inflammatory agents and/or decreasing the number of spreading 
depolarizations that occur during the acute phases of stroke (Peruzzotti-Jametti et al., 
2013; Notturno et al., 2014). 
It is unclear whether tDCS selectively affects neurons in the stimulated area or 
whether the influence of tDCS extends to all types of stimulated neurons.  With this in 
mind, tDCS could be exerting an effect by increasing or decreasing the activity of 
specific neuronal subtypes.  
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OBJECTIVES 
The aim of acute ischemic stroke care should represent best efforts to save 
penumbral tissue, as studies have concluded that survival of the penumbra is the most 
important determinant of recovery after acute ischemic stroke (Guadagno, 2003) and 
there is a high correlation between the amount of penumbral tissue saved and 
spontaneous neurologic recovery (Herholz, 2000). Functional studies of cortical 
electrophysiology and metabolic activity in the critical period after stroke have pointed to 
specific breakdowns in inhibitory circuitry, but these findings do not yet have a basis in 
neuroanatomy. As a result of not having established a neuroanatomical basis for this 
electrical imbalance in the brain after ischemic injury, the development of both acute and 
long-term therapies designed to treat this pathophysiological response have been 
hindered.  
Currently, intravenous thrombolysis with tPA administered within 4.5 hours of 
the onset of symptoms represents the current standard of care for safe and effective 
ischemic stroke treatment in clinical settings (Aminoff et al., 2015). Endovascular 
therapy is an emerging and promising intervention as well. Though shown effective in 
restoring blood flood to the cerebral tissue, neither therapy is designed to target the 
delayed brain injury caused by the imbalance in neuronal circuitry after stroke. 
Furthermore, according to the American Heart Association approximately 55% of stroke 
deaths in 2010 occurred out of the hospital, highlighting the need for early intervention in 
pre-hospital settings (Go et al., 2014). Additionally, ischemic stroke patients not eligible 
for intravenous thrombolysis treatment or endovascular operations necessitate alternative 
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therapeutic approaches to acute intervention. However, the application of direct current 
stimulation of the cortex in the immediate period after stroke may represent a novel 
therapy that not only serves to mitigate the maladaptive effects of electrical imbalance in 
the brain after stroke but also resolves temporal issues that plague the current standard of 
care. 
 Thus, the purpose of this study is to utilize immunohistochemistry techniques to 
identify a neuroanatomical basis and mechanism for the electrical imbalance in the brain 
after stroke and determine if transcranial direct current stimulation of the injured cortex 
exerts neuroprotective effect by altering electrical balance in a rat model. Specifically, the 
goals of this study are: 
(1) Use immunohistochemistry with a neuronal marker of neuronal activity as a 
well-establish technique in metabolic-based neuronal pathway tracing in order 
to define functional changes in network activation after stroke as well as 
changes that occur after stroke followed by transcranial direct current 
stimulation. 
 (2) Test the a priori hypothesis that transcranial direct current stimulation applied 
in the acute phase of stroke will have a polarity-specific changes in infarct 
volumes and brain swelling in the rat. 
(3) Use immunohistochemistry to establish a histological basis for the phenomena 
of disinhibition due to functional diaschisis after stroke, and determine if 
tDCS exerts a polarity specific effect on altered network function.  
  
  19 
METHODS 
 
2.1 Animals and animal care 
20 male Sprague Dawley rats (CD® IGS Rats, Charles River Laboratories 
International, Inc., Wilmington, MA, USA) at least 60 days old and weighing 300–655 
grams at the time of the operation were used in the study. All animals were housed in a 
temperature and humidity controlled environment with temperature maintained at 21° C, 
and animals kept under 12-hour daylight cycle. Animals were provided with food and 
water ad libitum. All experiments were approved by Institutional Animal Care and Use 
Committee (IACUC) of the Boston University School and conducted according to the 
National Research Council’s Guidelines for the Care and Use of Mammals in 
Neuroscience and Behavioral Research. Effort was made to minimize the number of 
animals used in the investigation.  
 
2.2 Experimental groups  
Animals were randomly assigned to one of five experimental groups. All five 
experimental groups utilized for immunohistochemical analysis and ischemic lesion 
volume measurement studies. Four of the five groups of animals underwent the identical 
surgical procedure and photochemical induced infarction as described previously 
described to the point of tDCS administration.  
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2.2.1 Ischemia and tDCS stimulation experimental groups 
The first group (“N-tDCS-Photothrombic”) composed of 6 animals was subjected 
to photothrombic-induced ischemia targeted at the somatosensory cortices of the left 
cerebral cortex without subsequent administration of tDCS. The second and third groups 
were comprised of 5 animals each and were subjected to the identical photothrombic-
induced ischemia targeted at the sensorimotor cortex of the left cerebral hemisphere. The 
animals of these groups received either a cathodal tDCS (“C-tDCS-Photothrombic”) or 
an anodal tDCS stimulation paradigm (“A-tDCS-Photothrombic”) 20 to 30 minutes post 
administration of rose bengal.  
2.2.2 Sham operated experimental groups 
The remaining two sham-operated experimental groups, each comprised of 2 
animals, were utilized as control measures for photothrombic occlusion and surgical 
procedure. The “ischemia sham” experimental group controlled for the effects of 
ischemia and therefore, animals of this group were administered sterile 0.9% saline 
solution intravenously through a tail vein catheter instead of rose bengal, avoiding 
photochemical induction of focal cortical infarction but still receiving at least twenty 
minutes of illumination of the skull by cold, white light. To control for potential stress 
responses evoked during the surgical operation and cofounding neurologic effects of 
anesthesia, a second sham-operated group was created (“surgical sham”). Animals of this 
experimental group were not operated on but instead received a lethal dose of sodium 
pentobarbital and were euthanized shortly thereafter, avoiding the anesthetization with 
isoflurane and Buprenex® injections. 
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2.3 Surgical procedures 
Surgery was performed to produce a focal ischemia of cerebral cortex, with or 
without subsequent transcranial direct current stimulation. Sterile surgical technique was 
utilized in all surgical procedures and surgeries were carried out in an aseptic 
environment. 
2.3.1 General surgical preparation 
Spontaneously breathing animals were initially anesthetized in an induction box 
containing 4% isoflurane aerosolized in 100% O2 delivered at a rate of 600 milliliters per 
minute. Isoflurane content was reduced to 2.0% by a close-fitting fitting nose cone for the 
remainder of the surgery. A catheter was inserted into either the right or left lateral tail 
vein, approximately 5 to 10 cm proximal to the tip of the animal’s tail. Once placed, the 
catheter was flushed with 1–2 milliliters of bacteriostatic 0.9% saline solution over the 
course of 60 seconds to verify correct insertion of the catheter and that the vein was not 
perforated. In cases where saline flushes resulted in syringe plunger resistance or the tail 
around the injection site blanched white, the catheter was withdrawn and IV access was 
established at a new site proximal to the original injection site or the experiment was 
aborted. Once intravenous access was verified, the catheter was secured in place with 
surgical tape.  In the case of aborted experiments, rats were recovered on a hot pack and 
returned to the colony for at least one week prior to a subsequent experiment. 
After induction of anesthesia, the animal’s head was mounted on a stereotaxic 
frame (David Kopf Instruments, Tujunga, CA, USA) and placed on a thermostatically 
controlled heating pad. The animal’s core body temperature was monitored by a rectal 
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temperature probe (Homoeothermic Blanket Control Unit, Harvard Apparatus, Holliston, 
MA, USA). In this way the animal’s core temperature was maintained at 37.0–38.0˚ C 
throughout surgical procedures and stimulation. A 12-cm2 area on the dorsal aspect of 
the animals’ head was shaved with electric clippers and subsequently cleaned with 70% 
isopropyl alcohol and a 0.5% chlorhexidine gluconate broad-spectrum antimicrobial 
solution (Vétoquinol, USA).  
An approximately 3 cm midline incision was made along the dorsal aspect of the 
animal’s head. The epicranial tissue was retracted to expose the calvarium. The exposed 
skull area was cleaned with 70% isopropyl alcohol and the skull was dried with sterile 
surgical pads.  
2.3.2 Induction of focal cerebral photochemical thrombosis  
To induce photochemical thrombosis in the left hemisphere of the cerebral cortex, 
a fiber-optic bundle with a 3 mm aperture connected to a fiber optic light source (lamp 
KL1500 LCD; Ealing, USA) was positioned for local illumination on the exposed skull 
anterior to bregma and lateral to the sagittal suture on the parietal bone. Care was taken to 
target the somatosensory cortices caudal to bregma of the left hemisphere according to 
stereotaxic coordinates provided by Paxinos and Watson (4th edition, 1998) by centering 
the light source at least 2.0 mm caudal to bregma and at least 3.5 mm left to the sagittal 
suture. Photothrombosis of the motor cortex was avoided by placing the most medial 
border of the light source at least 2 mm left of the sagittal suture in order to prevent 
confounding behavioral deficits caused by damage in this cortical region.  
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Figure 1. Approximate location of illumination to 
induce photothrombosis. Cold, white light from a 
fiber optic bundle was placed directly on the 
calvarium for 20 minutes following intravenous 
administration of the photosensitive dye rose bengal. 
In a dark room, the skull was illuminated with a cold, white light (180,000 
candela/m2). Within the first minute of illumination, 95% rose bengal (Sigma-Aldrich, 
Saint Louis, MO, USA) dye prepared to a concentration of 10 mg/mL in bacteriostatic 
0.9% sterile saline solution was slowly administered intravenously over the course of a 
sixty seconds interval according to a body dose of 0.130 mL/kg body weight 
(Buchkremer-Ratzmann & Witte, 1997). After dye administration, 1–2 ml of 
bacteriostatic 0.9% saline was injected 
intravenously over the course of sixty 
seconds to flush the catheter of 
residual dye. The animal was left 
undisturbed for twenty minutes 
following dye administration. At the 
end of twenty minutes the light source 
was removed from the surface of the 
animal skull (Fig. 1).  
 
2.3.3 Incision closing and post-operative care 
The tail vein catheter was removed and the calvarium cleaned with 70% isopropyl 
alcohol and 0.5% chlorhexidine gluconate. The incision was closed with 9 mm stainless 
steel wound clips and the closed incision site was disinfected. Immediately following 
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closure of wound, animals were subcutaneously administered 0.3 mg/mL Buprenex® 
(buprenorphine hydrochloride, Reckitt Benckiser Pharmaceuticals, Inc.), a parenteral 
opioid analgesic, dosed at 0.025 mg/kg body weight. Animals received additional doses 
of Buprenex® (0.025 mg/kg, s.c.) for pain management every 10–12 hours thereafter. 
Following retraction of the rectal temperature probe, the animals were removed from the 
stereotaxic frame and placed in a warm recovery cage for approximately 30–60 minutes. 
Once moving around, the animals were returned to their cages and provided with food 
and water ad libitum.  
2.3.4 Single-session transcranial direct current stimulation 
Following photochemically induced thrombosis and prior to wound closure, a 
self-adhering epicranial-stimulating electrode (Uni-Tab® Stimulating Electrodes, 
Covidien, Ltd.) comprised of a carbon conductor and pictographic storage liner was 
mounted on the parietal bone of calvarium over the location of the focal illumination in 
A-tDCS-Photothrombic and C-tDCS-Photothrombic animals. The epicranial-stimulating 
electrode had a defined contact area of 25mm2 for all stimulation experiments. Following 
stimulating electrode placement, an approximately 9cm2 area of the animals’ dorsum was 
shaved, cleaned with 70% isopropyl alcohol and a counter electrode was placed on the 
skin midline along the vertebral column. The counter electrode had a defined contact are 
of 25mm2 for all stimulation experiments and was adhered to the skin with a low 
impedance highly conductive gel electrode paste (Elefix EEG Electrode Paste, Nihon 
Kohden Corporation, Japan).  A total dose of 10.0 mA of anodal-tDCS (A-tDCS) or 
cathodal-tDCS (C-tDCS) was administered continuously for 5 minutes at an output of 2.0 
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mA using a constant DC current source (ActivaDose® II Iontophoresis Delivery Unit, 
ActivaTek, Inc., Salt Lake City, UT, USA). The chosen parameters led to a current 
density of 80 A/m2 (8 mA/cm2) with a total of 24000 charge/m2. This was found to be a 
desired current density as it fell below previously determined 142.9 A/m2 tDCS 
thresholds at which brain lesions occurred in rats (Liebetanz et al., 2009) and was similar 
in magnitude to previous studies that showed a neuroprotective effect of C-tDCS applied 
at a current density of 5.5 mA/cm2 (Peruzzotti-Jametti et al., 2013). 
On the first day of stimulation experiments, the investigator was blinded to the 
stimulation polarities and animals were randomized into N-tDCS-Photothrombic (n = 6), 
C-tDCS-Photothrombic (n = 5), A-tDCS-Photothrombic (n = 5), surgical sham (n = 2) 
and ischemia sham (n=2) experimental groups. 
2.3.5 Euthanasia  
One day after photochemical induction of thrombosis, the animal was injected 
with a lethal dose of sodium pentobarbital (50 mg/kg, i.p.). The animal received 
sequential intracardiac injections of 0.05 mL injection of anticoagulant heparin sodium 
(1,000 USP units/mL, Fresenius Kabi USA, LLC, Lake Zurich, IL) and 0.05 mL 
vasodilator sodium nitrite (1% w/v). The animal’s vascular system was perfused through 
the ascending aorta with approximately 450 mL of fixative solution (4% 
paraformaldehyde in 0.1M Phosphate Buffer Solution (PBS), pH=7.40) for twenty 
minutes. 
The brain was rapidly extracted with care, photographed and post-fixed in 4% 
paraformaldehyde in 0.1M PBS (pH=7.40) for at least 12 hours in a 10˚C refrigerator. 
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The brain was then transferred to a 10% glycerol in 2% DMSO solution at 4˚C until the 
tissue sank and then transferred to 20% glycerol in 2% DMSO solution at 4˚C until the 
tissue sank. 
 
2.4 Histological procedures and analysis 
2.4.1 Tissue cutting and storage 
The dorsal and lateral aspects of the right cerebral cortex were scored for 
identification purposes prior to freezing with dry ice. Once frozen, the brain was adhered 
to a stage using frozen tissue embedding media (HistoPrepTM, Fisher Scientific, 
Waltham, MA, USA), covered in dry ice, and cut with a sledge microtome into 40µm 
thick coronal sections. Consecutive sections were serially collected into five series and 
stored free-floating in cryoprotectant solution. The tissue was then transferred to a -40°C 
freezer until further processing for immunohistochemistry or stained for Nissl substance 
and Fluoro-Jade B. 
2.4.2 Fluoro-Jade B labeling 
In order to confirm the induction of photochemical thrombosis in the cerebral 
cortex, Fluoro-Jade B (Millipore Corporation, Temecula, CA) was selected for detection 
of gross and fine scale neuron degeneration.  A polyanionic fluorescein derivative, 
Fluoro-Jade B (FJ-B) is a sensitive probe of neurodegeneration and therefore ideal 
candidate for identifying infarcted tissue in the perilesional regions of the brain following 
stroke (Butler et al., 2002). Liu et al. observed a time-dependent increase in degenerating 
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neurons in which Fluoro-Jade B signal intensity peaked 24 hours after stroke (Liu et al., 
2009), indicating that this time point would provide a robust visualization of ischemic 
damage in the brain 1 day after photothrombic infarction.  However, one using this 
labeling method cannot distinguish between apoptotic and necrotic neurons. 
Coronal sections of brain tissue were mounted on to glass slides, allowed dry, and 
then processed with FJ-B according to standard protocols as described by Schmued & 
Hopkins (2000). FJ-B exhibited a green iridescence when visualized by a Leica TCS SPE 
Confocal Microsystem at an excitation peak at 480 nm and emission peak at 525 nm. FJ-
B stained coronal sections were digitized as partial brain hemisphere photomontages, 
using the ??x objective on a Leica TCS SPE Confocal Microsystem equipped with a 
motorized stage (Leica Microcsope Systems, Buffalo Grove, IL, USA).  Images were 
then processed identically using ImageJ software (version 1.49, NIH, Bethesda, MD, 
USA). 
2.4.3 Nissl Staining and Lesion Volume Quantification 
For each animal, a single series of tissue was selected for staining for Nissl 
substance. Coronal sections encompassing the anterior-posterior extent of the infarct 
were mounted sequentially on cleaned Superfrost Plus Microscope Slides (Thermo Fisher 
Scientific Inc., Waltham, MA, USA), allowed to dry, and Nissl stained according to 
standard protocols to detect any cortical lesions produced by the photochemical induced 
thrombosis.  
Computer-based planimetry was utilized in the determination of lesion area, 
ipsilateral cortex area, and contralateral cortex area of each image. Nissl stained sections 
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were transilluminated with a constant light field (Northern Light Illuminator) and 
digitized by a Nikon CCD camera connected to image analysis software (MCID™ Core, 
v. 7.0). The illumination level, camera height, and camera focus was kept identical for all 
images. Distance calibration was conducted on each image by measuring the number of 
pixels per millimeter. 
The image software package was utilized to collect measurements of lesion area, 
ipsilateral cortex area, and contralateral cortex area in each image. For each animal, the 
lesion volume was first calculated using the direct measure method, which employed the 
average end area formula for volume calculation (Equation 1). The volume of the 
ipsilateral and contralateral cortices were calculated summation of the areas of all brain 
slices from the same hemisphere and multiplying by the thickness between each section 
(Equations 2 & 3). The volume of the non-lesioned ipsilateral cortex was calculated by 
subtracting the direct measured infarct volume from ipsilateral cortex volume (Equation 
4). Finally, the “indirect method” described by Swanson et al. and Lin et al., which 
corrects for edema was used to calculate the lesion volume (Equation 5) (Swanson et al., 
1990; Lin et al., 1993). Lesion volumes were reported as percentage values of the 
contralateral cortex volume (Equation 6).  To estimate brain swelling from stroke, an 
edema index was calculated by subtracting the contralateral cortex volume from the 
ipsilateral cortex volume and then expressed a percentage of the contralateral hemisphere 
(Equation 7) (Notturno et al., 2014). !! = !! !! + !! + 2(!! + !! +⋯+ !!!!)             (1) 
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2.4.4 c-Fos immunolabeling  
Immunolabeling of neurons and glial cells was conducted on cut coronal brain 
sections from of all experimental groups as well as sham-operated animals. For 
immunohistochemical (IHC) analysis, coronal section of brain tissue were washed 
extensively in 0.05M Tris-buffered saline solution, pH=7.60 (TBS), incubated in a 
solution of 1.0% H2O2 in 0.05 M TBS for 36 minutes to quench endogenous peroxidase 
activity, washed extensively in 0.05M TBS. Sections were then incubated in 
SuperBlock™ (PBS) Blocking Buffer (Thermo Fisher Scientific Inc., Waltham, MA, 
USA) for 120 minutes to decrease non-specific staining. Afterwards, tissue sections were 
incubated for twenty-four hours at 21°C with the primary rabbit anti-c-Fos polyclonal 
antibody (ABE457; dilution 1:20,000; EMD Millipore Corp., Billerica, MA, USA) in 
0.05 M TBS, containing 2% Normal Donkey Serum (NDS), and 0.1% Triton-X. At then 
end of the incubation period, sections were washed in 0.05M TBS prior to a 120 minute 
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incubation at 21°C with the biotinylated secondary antibody (goat anti-rabbit IgG, 1:600; 
Vector, Burlingame, CA, USA) in 0.05 M TBS, containing 2% NDS, and 0.1% Triton-X. 
Sections were again washed in 0.05M TBS and then incubated for 60 minutes at 21°C in 
an avidin-biotin complex solution (VECTASTAIN® Elite ABC Kit, Vector Laboratories 
Ltd., Burlingame, CA, USA) in order to amplify the target antigen signal. Sections were 
washed in 0.05M TBS then developed in a chromogenic reaction with a nickel (II) 0.55 
mM 3-3’-diaminobenzidine (Sigma-Aldrich, Saint Louis, MO, USA) and 0.01% H2O2 
solution. The chromogenic reaction was limited to 5 minutes and terminated by 
extensively washing section in 0.05M TBS. 
2.4.5 Double labeling of c-Fos-immunolabeled neurons and glia 
In order to determine phenotypes of c-Fos-immunoreactive cells, double 
immunolabeling with chromogenic visualization was conducted. To identify neurons, 
mouse anti-NeuN monoclonal antibody (MAB377; dilution 1:5,000; EMD Millipore 
Corp., Billerica, MA, USA) was used. Rabbit anti-GFAP monoclonal (ab7260; dilution 
1:5000; Abcam Plc., Cambridge, MA, USA) was utilized to identify astrocytes. The 
following antibodies were used for the identification interneurons of the cortex: goat anti-
calretinin (CR) monoclonal antibody (CG1; dilution 1:5,000; Swant Inc., Switzerland), 
mouse anti-parvalbumin (PV) monoclonal antibody (PV23; dilution 1:5,000; Swant Inc., 
Switzerland), and rabbit anti-vasoactive intestinal peptide (VIP) polyclonal antibody 
(#20077; dilution 1:5,000; ImmunoStar, Hudson, WI, USA). Mouse monoclonal anti-
S100B (ab14849; dilution 1:5,000; Abcam Plc., Cambridge, MA, USA) was utilized as a 
marker of pathology.  
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Sections were first incubated for twenty-four hours at 21°C in a solution 
containing one of the aforementioned antibodies in 0.05 M TBS stock solution, 
containing 0.1% Triton-X and 2% normal serum of the corresponding animal source of 
the secondary antibody (NDS, Normal Goat Serum, or Normal Rabbit Serum). Sections 
were incubated at 4°C for an additional twenty-four hour period in the primary antibody 
solution. After extensive washing with 0.05M TBS, the sections were incubated for 120 
minutes in their respective biotinylated secondary polyclonal anti-IgG antibody (rabbit 
anti-goat IgG, goat anti-rabbit IgG, or goat anti-mouse IgG, 1:600; Vector, Burlingame, 
CA, USA) in their corresponding 0.05 M TBS stock solutions. Antigen localization was 
determined by an identical development process using VECTASTAIN® Elite ABC Kit 
and chromogenic reaction with 0.55 mM 3-3’-diaminobenzidine and 0.01% H2O2 
solution as described earlier for the chromogenic visualization of c-Fos immunoreactive 
cells. Once the double immunolabeling process was complete, the sections were mounted 
on cleaned Superfrost Plus Microscope Slides (Thermo Fisher Scientific Inc., Waltham, 
MA, USA), allowed to dry overnight and then dehydrated in three washes of 100% 
ethanol, cleared with three washes with xylenes, and covered slipped with Depex 
Mounting Media.  
To control for immunolabeling specificity of the respective target antigen, at least 
one section was omitted from incubation in a primary antibody. In this way, no 
immunolabeling was ever observed in the developed control sections. 
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2.4.5 Microscopic qualification of double immunolabeled Cells 
Double immunolabeled sections were surveyed under high power for distinct 
staining patterns and cell phenotype identification. Two to three sections per animal were 
analyzed for each immunolabeling paradigm. Cortical areas as well as other regions of 
interest of the infarcted hemisphere and intact contralateral hemisphere were surveyed in 
depth, in each case the latter one served as a control. Cortical areas of the lesion region, 
perilesional area, subcortical white matter and the corresponding areas of the contralateral 
cortex were of particular interest.  
2.4.6 Photo analysis of double immunolabeled cells 
IHC stained coronal sections were digitized as whole brain hemisphere 
photomontages, using the 10x objective on an E600 Nikon microscope equipped with 
Turboscan Montaging system (Objective Imaging, UK). Using ImageJ, the high-
resolution images from each animal were processed identically using ImageJ software 
(version 1.49, NIH, Bethesda, MD, USA). Regions of interest on each tissue section were 
surveyed and observations documented.  
 
2.5 Statistical Analysis  
2.5.1 One-way ANOVA analysis of treatment effect  
Prior to one-way ANOVA testing, the homoscedasticity of the distribution of 
infarct volumes as a percentage of the contralateral cortex volume (%I) and the edema 
index in each experimental group were tested. A Shapiro-Wilk test of the data revealed 
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that the %I and edema index in each experimental group were normally distributed. 
Despite the small sample sizes, parametric testing was undertaken. A one-way ANOVA 
test was conducted to determine if applying transcranial direct current stimulation 
exhibited a treatment effect on the average cerebral infarct volumes in male Sprague-
Dawley rats 1 day after photothrombic stroke, under no stimulation, single-session 
cathodal stimulation, and single-session anodal stimulation conditions. Significance level 
was determined at p < 0.05. 
2.5.2 Independent sample t-test of a priori hypotheses  
The a priori hypotheses that single-session C-tDCS would demonstrate a 
treatment effect 1 day after photothrombic stroke and single-session A-tDCS application 
would not demonstrate a treatment effect were tested parametrically. Specifically, a one-
tail independent-sample t-test was conducted to compare the %I and edema index of C-
tDCS-Photothrombic and N-tDCS-Photothrombic treatment groups. Similarly, a one-tail 
independent-sample t-test was conducted to compare, A-tDCS-Photothrombic and N-
tDCS-Photothrombic experimental groups. Significance level was determined at p < 0.05. 
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RESULTS 
 
3.1 Effect of photothrombic stroke on brain macro- and microscopic anatomy 
3.1.1 Stroke size, location and quantification 
Application of a wide-band cool white light (3mm diameter) through the skull in 
the presence of intravenous rose bengal produced a focal infarct in the underlying left 
cerebral cortex.  The brains of surgical sham animals and ischemia sham animals did not 
exhibit macroscopic or microscopic lesions. The infarct (n=6) had an average volume of 
9.89mm3±2.65 SEM when controlling for edema. As a percentage of the contralateral 
hemisphere volume, the infarct was on average 3.09%±0.668 SEM and animals of this 
group exhibited an average edema index, a measure of brain swelling after stroke, of 
8.65%±1.54 SEM (Table 2; Fig. 5). 
The infarct extended throughout the depth of the cortex, with some cases 
involving cortical white matter. The variability in size was thought to be due to partial 
obscuring of the light by emerging blood or fluid during the period of illumination 
(180,000 cd/m2 for 20 minutes) and resulted a reduced dosing of the light to the cortex. In 
certain animals there appeared to be a mismatch between the superficial area size of the 
induced lesion and the diameter of the light aperture, which may have been due to 
oblique diffraction of the light path. Animals that exhibited a mismatch ratio (superficial 
lesion surface area/surface area of light aperture) of less than 0.90 were excluded from 
the study. 
  35 
3.1.2 Microscopic analysis 
The lesion was evaluated by three main separate series of sections.  One series 
was processed for Nissl substance to stain all cells, one group of sections were processed 
for immunocytochemistry with an antibody to the protein product of the immediate early 
gene c-fos (c-Fos), and a subset of animals had sections that were stained for the presence 
of Fluoro-Jade B (FJ-B), a marker of neuronal death.  Additional sections were examined 
that were stained for GFAP, a marker of the intermediate filaments in astrocytes, and 
S100B, a marker of activated astrocytes.  Other sections were evaluated for the presence 
of VIP, calretinin, and parvalbumin proteins that are expressed in inhibitory neurons. 
3.1.3 Nissl-stained sections 
Nissl stained sections showed an absence of grey matter where the light was 
targeted.  Around the lesion, a halo of cells with the size and morphology of neurons 
were identified that were embedded in intact neuropil.  These cells displayed light 
staining relative to other neurons, and a shrunken profile.  These cells were present within 
a region of what has previously been referred to as the penumbra or perilesional area.  
This area also contained other cells whose size and morphology were smaller than the 
neurons – these cells were inferred to be glial cells.   
3.1.4 c-Fos IHC-stained sections 
Immunohistochemistry for c-Fos revealed staining confined to nuclei.  Labeled 
nuclei were found in the perilesional area, and throughout the cerebral cortex.  Labeled 
neurons were consistently found in the central nucleus of the amygdala (CeM), the 
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anterodorsal part of medial amygdaloid nucleus (MeAD), the arcuate nucleus (Arc) of the 
hypothalamus, the dorsal hypothalamic area (DA), the piriform cortex, and the cingulate 
cortex. Isolated neurons were found consistently in the paraventricular nucleus of the 
thalamus as well as the central medial thalamic nucleus area.  Interestingly, there were no 
consistent populations neurons identified in the contralateral homotypic cortex, nor were 
c-Fos positive (c-Fos+) neurons found outside of the perilesional zone with two notable 
exceptions as detailed below. 
In the perilesional zone, c-Fos+ neurons were identified by their shape and their 
size.  Some cells, however, had stained nuclei insufficiently large to be called neurons; 
that criterion as well as their number and distribution suggested that glial cells 
surrounding the lesion (in the gray and white matter) also exhibited c-Fos+ staining.  This 
staining of glial cells has been previously reported in vivo following ischemia (Herrera & 
Robertson, 1989), brain injury (Dragunow & Robertson, 1988), and hypoxia-ischemia in 
infant rats (Gunn et al., 1990), and may be a result of 1) the expression of c-Fos protein 
stimulated by such an environment, or 2) a local altered microenvironment that resulted 
in a non-specific staining of nuclei that did not have c-Fos expression. 
There were two other regions that displayed consistent c-Fos activation.  The first 
was in the intact ipsilesional cortex lateral to the lesion.  Scattered clusters of c-Fos+ 
neurons were found in layer III; these neuronal clusters were identified in all animals and 
extended typically 1 to 2 mm from the lesion into the adjacent intact somatosensory 
cortex (Fig. 2B).  The second region of consistent c-Fos activation was in the ipsilateral, 
corpus callosum, and contralateral white matter.  Though some of these cells were 
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confirmed to be white matter neurons by double labeled c-Fos neurons with the pan-
neuronal stain NeuN, the majority were not found to be neurons (Fig. 6C).  Moreover, 
these c-Fos positive cells did not exhibit double label with makers of glia cells (GFAP) 
(Fig. 8B) or activated astrocytes (S100B) (Fig 9B), indicated they were not astrocytes. 
Additionally, these consistent populations of c-Fos+ neurons were not inhibitory in 
nature. IHC co-staining revealed that the vast majority of the c-Fos+ neurons of either 
region did not co-express PV (Fig. 10B), CR (Fig. 11B), and VIP, known markers of 
GABAergic inhibitory neuron subtypes. 
3.1.5 Fluoro-Jade stained sections 
FJ-B staining was observed in the immediate perilesional area.  Neurons in this 
area had a variety of morphologies, and smaller cells with glial-like distribution or 
appearance were not observed (Fig. 4C).  This staining was more or less uniform in 
thickness and illustrated a region of evolving cell death, similar to a penumbra.  In 
addition, Fluoro-Jade staining revealed intermittent clusters of stained neurons that 
extended as far as 6mm lateral to the lesion (Fig. 3A; Fig. 4A).  Many of these neurons 
appeared to have a pyramidal-like morphology (Fig. 3C; Fig. 4D), although cells with 
lower staining density were observed with the stain localized to a circular area.  All 
neurons appeared to be located in upper layer 5 (Fig. 3B; Fig. 4B).  No staining was 
observed in any other layer, or between the clusters of labeled cells.  While these cells 
were not double-labeled with c-Fos+, their location and orientation were consistent with 
the c-Fos+ neurons noted above.  Examining the same region on adjacent Nissl-stained 
sections revealed clusters of cells in the same area with lighter staining cytoplasm, likely 
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reflecting a dissolved Nissl substance.  
3.1.6 GFAP/c-Fos double IHC stained sections 
Immunohistochemistry directed against GFAP revealed hypertrophic GFAP+ 
cells, identified by their star-shaped morphology and swollen dark brown colored somas 
and processes, in the perilesional as well as the intact ipsilateral and contralateral 
subcortical white matter (Fig. 8A). A diffuse mixture of GFAP+ reactive granules, 
fragmented processes and residual star-shaped cell elements, likely the result of 
dissolving astrocytes that had swollen beyond membrane capacity, were also observed 
within the perilesional area and white matter (Fig. 8B). There was no indication of a 
strong GFAP immunoreactivity in the adjacent ipsilateral cortical regions or the 
homotopic region contralateral to the infarct. Additionally, GFAP immunoreactivity did 
not overlap with c-Fos immunoreactivity in the perilesional, cortical or white matter areas 
investigated or the Fluoro-Jade B labeled cells in upper layer Va. However, GFAP 
immunoreactive cells were found within the same peri-lesional area as the Fluoro-Jade B 
signal. 
3.1.7 S100B/c-Fos Double IHC Stained Sections 
S100B immunoreactive (S100B+) cells and processes were identified by a dark 
brown coloration using IHC. However, compared to IHC for GFAP, S100B+ cell 
morphology was less defined and coloration was found to be more granular.  S100B 
immunoreactivity was found to exhibit a complimentary pattern and orientation of 
activity to those revealed by GFAP IHC (Fig. 9A). S100B+ cells, processes and granules 
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were found to be strongly active in the perilesional area and white matter (Fig. 9B).  
Presumably, these results are indicative of ischemia-induced astrocytic activation and 
astrogliosis in both the penumbra and the subcortical white matter. S100B 
immunoreactivity was not detected in the adjacent ipsilateral cortical areas or the 
contralateral homotopic cortical areas indicating astrogliosis was limited to the 
perilesional area and white matter. S100B immunoreactivity was not found to co-localize 
with c-Fos immunoreactivity in the cells of the perilesional or white matter areas or any 
other areas of the brain investigated. 
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Figure 2. Peri-lesional and somatosensory neurons visualized by c-Fos IHC. (A), (C) and (E) 
Survey view of coronal section of representative N-tDCS-Photothrombic (A), C-tDCS-
Photothrombic (C) and A-tDCS-Photothrombic (E) animals reveals c-Fos immunostained 
neurons and glial in the ipsilateral cortex. Region of interest (ROIs) are identified by black 
outline. (B), (D) and (F) Higher magnification of (A), (C) and (E), respectively. White arrows 
highlight c-Fos immunolabeled neurons in layer II/III of the somatosensory cortex. Scale bars = 
500µm in (A), (C) and (E); 250µm in (B), (D) and (F). 
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Figure 3. Transneuronal degeneration layer Va somatosensory degenerating neurons 
visualized by Fluoro-Jade B. (A) Survey view of coronal section +0.48mm to +0.20mm bregma 
of a representative N-tDCS-Photothrombic case reveals degenerating neurons around the lesion 
as well as across layer V of the adjacent somatosensory cortex. ROIs are identified by white 
outline. (B) Higher magnification of (A). (C) Individual FJ-B labeled cells of layer Va found in 
(B). ROIs are identified by white outline. Scale bars = 1000µm in (A); 500µm in (B); 20µm in 
(C). 
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Figure 4. Caudal peri-lesional and layer Va somatosensory degenerating neurons visualized 
by Fluoro-Jade B. (A) Survey view of coronal section -1.40mm to bregrma of representative N-
tDCS-Photothrombic reveals degenerating neurons around the lesion as well as across layer V of 
the adjacent somatosensory cortex. ROIs in white boxes. Cortical layer distinctions in white. (B) 
Higher magnification of layer V ROI in (A). (C) Higher magnification of peri-lesional ROI in 
(A). (D) Higher magnification of individual pyramidal neurons from ROI in (B). Scale bar = 
500µm in (A); 100µm in (B), (C), and (D). 
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3.2 Effect of tDCS on ischemic lesion macro- and microscopic anatomy 
3.2.1 Stroke size, location and quantification 
To investigate the effect of tDCS on ischemic lesion macro- and microscopic 
anatomy, photothrombic infarction was induced in animals of two randomized treatment 
groups in the left cortex as previously described wide-band cool white light (3mm 
diameter) through the skull in the presence of intravenous rose bengal. Immediately 
following lesion induction, animals were given a single-session of either cathodal tDCS 
(C-tDCS) or anodal tDCS (A-tDCS) at a current density of 80 A/m2. One day later, the 
infarct of the C-tDCS-Photothrombic treatment group (n=5) had an average volume of 
5.23mm3±1.43 SEM when controlling for edema. As a percentage of the contralateral 
hemisphere volume, the infarct was on average 2.07%±0.453 SEM. Animals of the A-
tDCS-Photothrombic treatment group (n=5) had an average infarct of 14.2mm3±6.09 
SEM, alternatively 4.47%±1.60 SEM one day after stroke and controlling for edema (Fig. 
5). C-tDCS-Photothrombic and A-tDCS-Photothrombic treatment groups exhibited an 
average edema index of and animals exhibited an edema index of 6.89%±0.861 SEM and 
7.97%±1.45 SEM, respectively (Table 2).  
As with animals that underwent photothrombic stroke but did not receive single-
session stimulation, the infarct extended throughout the depth of the cortex, with some 
cases involving cortical white matter.  Again, variability in size was thought to be due to 
partial obscuring of the light by emerging blood or fluid during the period of illumination 
and thus a reduced dosing of the light to the cortex. Animals that demonstrated a ratio of 
superficial lesion surface area to surface area of the light aperture of less than 0.90 were 
 44 
Table 2. Study of brain infarct volume after Photothrombic stroke and single-session tDCS in rats. Value are mean±SEM; p 
reflecting significance level of difference among group was calculated for each parameter using one-way ANOVA. 
Treatment 
Group n 
Infarct volume 
(mm3) 
Total cortex volume 
(mm3) Noninfarcted 
cortex 
volume in left 
cortex (mm3) 
Infarcted 
volume in left 
cortex (direct 
measurement) 
(mm3) 
Infarct volume 
% of right 
cortex volume 
(%I) 
Edema 
index Right 
cortex 
Left cortex 
(direct 
measure) 
Right cortex Left cortex  
N-tDCS-
Photothrombic 6 0 36.8±7.74 301±18.6 328±23.0 292±16.2 9.89±2.65 3.09±0.688 8.65±1.54 
C-tDCS-
Photothrombic 5 0 22.4±4.54 259±23.6 242±20.6 237±19.5 5.23±1.43 2.07±0.453 6.89±0.861 
A-tDCS-
Photothrombic 5 0 35.5±13.6 306±44.1 281±37.8 270±31.82 14.2±6.09 4.47±1.60 7.97±1.45 
P value   0.502 0.295 0.302 0.260 0.298 0.284 0.659 
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excluded from the study. 
 
3.2.2 Single-session tDCS does not have a significant effect on lesion volume or brain 
swelling 
The one-way ANOVA results demonstrated no treatment effects of the single-
session stimulation paradigms on the volume of cerebral infarction as a percentage of the 
contralateral cortex volume.  There was not a significant treatment effect of stimulation 
on average infarct volumes at the p < 0.05 level for the three experimental conditions 
(F(2,13) = 1.388; p = 0.284). Moreover, one-way ANOVA demonstrated that stimulation 
did not have an effect on brain swelling represented by the calculated edema index at the 
p < 0.05 significance level (F(2,13) = 0.431; p = 0.659).  The results suggest that 
application of our tDCS paradigms do not have a significant effect on the size of infarct 
volume or edema 1 day after stroke.  
A one-tailed independent sample t-test assuming equal variances did not show a 
significant difference in lesion volume as a percentage of contralateral cortex volume 
between the C-tDCS-Photothrombic and N-tDCS photothrombic treatment groups. There 
was not a significant difference in the infarct volumes of animals that received our C-
tDCS paradigm (M=2.067%±0.453 SEM, SD=1.013) and those that did not receive 
stimulation (M=3.094%±0.668 SEM, SD=1.636; t(9)=1.216, p = 0.128) (Table 2; Fig. 5).  
Furthermore, a significant difference was not observed in the average infarct volumes of 
animals that received the single-session A-tDCS paradigm (M=4.474%± 1.60 SEM, 
SD=3.57) (Table 2; Fig. 5) and those that did not receive any stimulation (t(9)=-0.853, p 
= 0.416) using a one-tailed independent sample t-test.  
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Thus, the a priori hypotheses that single-session C-tDCS would demonstrate a 
neuroprotective effect and single-session A-tDCS would expand the lesion volume was 
not found to be valid. These results suggest that our single-session C-tDCS and A-tDCS 
paradigms do not have the hypothesized neuroprotective and neuropathological effects on 
average infarct volume 1 day after stroke. Specifically, our results suggest that when rats 
receive single-session C-tDCS or A-tDCS therapy immediately after stroke, the average 
infarct volume that develops does not increase or decrease when compared to rats that did 
not receive the therapy.  
Figure 5. tDCS did not significantly reduce or enlarge average infarct volume as a % of the 
unaffected hemisphere. Single-session C-tDCS and A-tDCS did not have a statistically 
significant effect on the size of infarct volumes when compared to non-stimulated animals.  
3.2.3 Microscopic analysis 
Identical approaches to evaluating the microscopic effects of C-tDCS and A-tDCS 
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on ischemic lesion anatomy were utilized as those undertaken in the investigation of 
photothrombic stroke on brain macro- and microscopic anatomy. Specifically, three main 
separate series of sections processed with Nissl substance, c-Fos IHC, and FJ-B were 
evaluated from each of the C-tDCS-Photothrombic and A-tDCS-Photothrombic treatment 
groups. Sections were examined for potential polarity-specific stimulation effects on 
astrogliosis using GFAP and S100B IHC staining. Using IHC double staining techniques, 
additional sections from both stimulation treatment groups were examined for the co-
expression of c-Fos with PV (Fig. 10), CR (Fig. 11), and VIP proteins in GABAergic 
inhibitory neuron subtypes.   
3.2.4 Nissl stained sections 
Nissl stained sections of either C-tDCS-Photothrombic or A-tDCS-Photothrombic 
animals did not demonstrate any differences in the loss of grey matter where the light was 
targeted. The arrangement of the perilesional area and resident cells found within did not 
differ from those found in animals that did not receive the single-session stimulation 
paradigms.  
3.2.5 c-Fos IHC-stained sections 
Photothrombic ischemia elicited a similar pattern and arrangement of c-Fos 
immunoreactivity in C-tDCS-Photothrombic and A-tDCS-Photothrombic animals as 
those of the N-tDCS-Photothrombic animals (Fig. 2).  c-Fos+ neurons were again found 
consistently in brain structures such as the CeM, MeAD, Arc, DA, piriform cortex and 
cingulate cortex as well as the similar areas in the thalamus.   
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As with the N-tDCS-Photothrombic group, two regions displayed consistent c-Fos 
activation in the animals receiving single-session C-tDCS. In the majority of animals 
receiving single-session C-tDCS a population of c-Fos+ neurons in cortical layer III was 
found to extend 1 to 2 mm along the somatosensory cortex from the perilesional area 
(Fig. 2D).  Although animals in the C-tDCS-Photothrombic group exhibited a degree of 
variability in the appearance of this population, based on arrangement and orientation, 
this population of c-Fos+ neurons is most likely same activated population consistently 
identified in N-tDCS-Photothrombic animals.  Moreover, like their N-tDCS-
Photothrombic counterparts, IHC staining in the animals of the C-tDCS-Photothrombic 
group did not reveal a corresponding population of c-Fos+ neurons in the contralesional 
homotypic cortex. The second region to consistently exhibit c-Fos+ reactivity was the 
contralateral white matter and the majority of these cells were not found to co-
localization with NeuN+ IHC staining neurons.  
Figure 6. White matter neurons are visualized by NeuN IHC. (A) Survey view of coronal section 
of representative N-tDCS-Photothrombic animal reveals widespread c-Fos and NeuN 
immunostaining. Region of interest (ROIs) are identified by block outline. (B) Higher magnification 
of ROI in (A) reveals widespread c-Fos+ and NeuN+ immunostained white matter cells. (C) Higher 
magnification of ROI in (B) demonstrates individually NeuN+ immunostained neurons (red arrows) 
and a cluster of non-neuronal c-Fos+ immunostained white matter cells (black arrow). Scale bars = 
1000µm in (A); 100µm in (B); 50µm in and (C). 
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A-tDCS-Photothrombic animals only 
demonstrated one region of consistent c-
Fos activation. Like their non-stimulated 
and cathodal stimulated counterparts, 
animals receiving single-session anodal 
tDCS exhibited a regular population of 
c-Fos+ cells, some of which were 
identified by co-localization with NeuN+ 
IHC staining as neurons, in the 
contralateral white matter. However, 
unlike the animals of the N-tDCS-
Photothrombic and C-tDCS-
Photothrombic groups, animals of this 
treatment group did not display a 
consistent population of c-Fos+ neurons 
in either the ipsilateral somatosensory 
cortex or contralateral homotypic cortex 
with the exception of one animal.  In 
one animal of this group a pattern of 
homogeneous c-Fos+ induction confined 
to the entire ipsilateral hemisphere akin 
to those evoked by spreading depressions (Gass et al., 1992) was observed (Fig. 7).  
Figure 7. c-Fos IHC reveals peri-infarct 
depolarization in an A-tDCS-Photothrombic 
animal. (A) The injured hemisphere demonstrate 
homogenous c-Fos immunostaining consistent 
with CSD/PIDs. (B) Higher magnification of ROI 
outlined in (A). Scale bar = 1,000µm in (A) and 
(B). 
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Notably, this pattern of c-Fos+ induction accompanied the appearance of PV+/c-Fos+, 
CR+/c-Fos+ and VIP+/c-Fos+ double IHC labeled cells in substantially higher frequency 
compared to all animals within and between treatment groups. The finding of CR+/c-
Fos+ and VIP+/c-Fos+ cells in this animal was isolated to the infarcted cortex and the c-
Fos+ immunoreactivity of the contralateral cortex and subcortical white matter remained 
comparable to the low levels observed in other animals of this treatment group.  
3.2.6 Fluoro-Jade stained sections 
The pattern of FJ-B staining observed in the immediate perilesional area of both 
C-tDCS-Photothrombic and A-tDCS-Photothrombic animals was similar to N-tDCS-
Photothrombic animals.  The staining around the lesion was more or less uniform in 
thickness and degenerating neurons comprising a heterogeneous mixture of morphologies 
can be identified in the area of evolving cell death. Unlike the non-stimulated animal, 
intermittent clusters of degenerating neurons that extended from the lesion in layer 5, or 
any other layer, were not revealed by FJ-B staining in either stimulation group.  
Furthermore, FJ-B+ cells were not found in any other remote regions of the brain, 
including the homotopic area of the contralateral hemisphere or thalamus across the two 
stimulation treatment groups. Fluoro-Jade B labeled cell appeared to correspond in 
location and orientation with c-Fos+ cells in the perilesional area in both treatment 
groups. 
3.2.7 GFAP/c-Fos double IHC stained sections  
In both A-tDCS-Photothrombic and C-tDCS-Photothrombic treatment groups a 
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consistent pattern of hypertrophic GFAP+ astrocytes around the lesion and within the 
ipsilateral white matter were revealed by IHC staining (Fig. 8). As with the IHC staining 
in N-tDCS-Photothrombic animals, there was no indication that this GFAP+ glial 
population co-expressed c-Fos in either treatment group. Furthermore, the absence of 
GFAP+ glial cells in the adjacent ipsilateral cortex or the contralateral homotopic regions 
indicated that single-session C-tDCS or A-tDCS, regardless of lesion depth, did not 
attenuate or exacerbate the glial response to stroke in these cortical regions of interest.  
The pattern of astrocytic activation and localization was found to be analogous to the 
pattern observed in that animals that were withheld post stroke single-session tDCS with 
one notable exception. In both A-tDCS-Photothrombic and C-tDCS-Photothrombic 
treatment groups GFAP+ astrocytes were not consistently observed in the contralateral 
white matter.  In either treatment group, at least one animal was found to not exhibit 
intensely stained hypertrophic GFAP+ cells and reactive granules in contralateral 
subcortical white matter. However, in either of these cases the lesion was shallow and did 
not span the cortex, preserving the cytoarchitecture of the contralateral white matter.  
3.2.8 S100B/c-Fos double IHC stained sections  
When compared with animals that did not receive stimulation and controlling for 
lesion depth and white matter integrity, IHC staining for S100B in A-tDCS and C-tDCS 
groups did not exhibit an appreciable effect on astrogliosis one day after stroke (Fig. 9).  
The pattern of S100B+ astrocyte localization to the perilesional region and ipsilateral 
white matter without co-expression of c-Fos in both C-tDCS-Photothrombic and A-
tDCS-Photothrombic animals corresponded with patterns observed in animals that did not 
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receive stimulation. However, astrogliosis was not consistently detected by S100B+ 
staining in the contralateral white matter. Analogous to the observation in GFAP IHC 
staining of stimulated animal groups, in cases were the lesion did not span the cortex and 
white matter, S100B immunoreactivity was not necessarily detected in the contralateral 
white matter. 
 
Figure 8. Peri-lesional reactive astrocytes visualized by GFAP/c-Fos IHC. Survey views of 
coronal sections of representative (A) N-tDCS-Photothrombic, (C) C-tDCS-Photothrombic, and 
(E) A-tDCS-Photothrombic (E) animals demonstrate non-overlapping GFAP+ reactive astrocytes 
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and c-Fos+ neurons in the peri-lesional area of the ipsilateral cortex. ROIs are identified by block 
outline. (B), (D) and (F) Higher magnification of (A), (C) and (E), respectively. Black arrows 
highlight individual GFAP immunolabeled astrocytes. Scale bars = 500µm in (A), (C) and (E); 
250µm in (B), (D) and (F).  
 
 
Figure 9. Peri-lesional astrogliosis visualized by S100B/c-Fos IHC. Survey views of coronal 
sections of representative (A) N-tDCS-Photothrombic, (C) C-tDCS-Photothrombic, and (E) A-
tDCS-Photothrombic (E) animals show S100B immunostained reactive astrocytes and c-Fos 
immunostained neurons in the peri-lesional area of the injured cortex. ROIs are identified by 
block outline. (B), (D) and (F) Higher magnification of (A), (C) and (E), respectively. Black 
arrows highlight individually S100B immunolabeled astrocytes in the peri-lesional area. Scale 
bars = 500µm in (A), (C) and (E); 250µm in (B), (D) and (F).  
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Figure 10. Inhibitory Interneurons visualized by parvalbumin/c-Fos IHC. Survey views of 
coronal sections of representative (A) N-tDCS-Photothrombic, (C) C-tDCS-Photothrombic, and 
(E) A-tDCS-Photothrombic (E) animals exhibit non-overlapping PV+ interneurons and c-Fos+ 
neurons in the peri-lesional area of the injured cortex. ROIs are identified by block outline. (B), 
(D) and (F) Higher magnification of (A), (C) and (E), respectively. Black arrows highlight PV 
immunolabeled interneurons in the peri-lesional area and adjacent somatosensory cortex. Scale 
bars = 500µm in (A), (C) and (E); 250µm in (B), (D) and (F).  
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Figure 11. Disinhibitory Interneurons visualized by calretinin/c-Fos IHC. Survey views of 
coronal sections of representative (A) N-tDCS-Photothrombic, (C) C-tDCS-Photothrombic, and 
(E) A-tDCS-Photothrombic (E) animals exhibit non-overlapping CR+ disinhibitory interneurons 
and c-Fos+ neurons in the peri-lesional area of the injured cortex. ROIs are identified by block 
outline. (B), (D) and (F) Higher magnification of (A), (C) and (E), respectively. Black arrows 
highlight CR immunolabeled interneurons in the peri-lesional area and adjacent somatosensory 
cortex. Scale bars = 500µm in (A), (C) and (E); 250µm in (B), (D) and (F). 
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DISCUSSION 
 
4.1 Summary of Findings 
The results of the present study demonstrated the following major findings: 
1. Histological staining with Fluoro-Jade B demonstrate that photothrombic stroke 
elicited neuronal transneuronal degeneration in a hemisphere-specific, layer-
specific, and population specific manner within 1 day of injury. 
2. The effects of low intensity single-session cathodal and anodal stimulation on 
network activity within the injured hemisphere, white matter, and contralateral 
hemisphere are minimal.  
3. c-Fos immunohistochemistry indicates the presence of a layer-specific 
alterations in neuronal activity to anodal and cathodal stimulation.  
4. Histological evidence does not support interneuron participation in 
hypothesized models of network disinhibition by functional diaschisis. 
5. The current paradigm of low intensity single-session tDCS exert 
neuroprotective and neuropathological effects in a polarity-specific manner but 
these effects are not found to be statistically significant given the low power of 
the study.  
 
4.2 Major Finding #1 Layer V transneuronal degeneration 
As far as can be determined, the finding of intermittent clusters of layer 5-specific 
neural degeneration by FJ-B labeling after stroke has not been previously described. The 
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exact pathological mechanism behind the intermittent spread of neurodegeneration in 
layer Va after stroke remains unknown, but there are two possibilities that may account 
for this finding.  The first possibility is that the loss of afferent signals to the FJ-B+ 
neurons may contribute to the selective neuronal death observed in this study. This 
process, called anterograde transneuronal degeneration, is a form of deafferentation 
characterized by neuronal death in distant areas innervated by the neurons within the 
primary lesion This phenomenon has been widely reported and observed previously in 
somatosensory pyramidal neurons undergoing apoptosis 1 day after unilateral transection 
of the olfactory bulb (Capurso et al., 1997) as well as in the barrel fields of mice 
following vibrissa injury at birth (Van der Loos & Woolsey, 1973; Simons et al., 1984). 
Given the elaborate network of intercortical as well as transcortical and interhemispheric 
connections (via the external capsule and corpus callosum) input layer V neurons are 
known to receive (Hefti & Smith, 2000; Schubert et al., 2001; Shepherd, 2013), it is quite 
possible that the cortical lesion, including destruction of the subcortical white matter, 
resulted in the loss of vital afferent input to these particular neurons.  The ability of 
extensive intracortical and thalamic connections to distant and separate cytoarchitectonic 
brain areas is congruent with this description of neurodegeneration. Furthermore, the 
absence of reactive astrocytes and evolving astrogliosis in the vicinity of these remote 
regions of neurodegeneration as revealed by GFAP and S100B IHC is representative of 
apoptosis, but not necrotic cell death (Kerr & Harmon, 1991).  
The second possibility is that the neurons labeled by FJ-B comprise a population 
of neurons whose axons have been destroyed by the lesion.  This damage leads to cell 
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death.  This form of retrograde degeneration is also established, and would likely be due 
to a subpopulation of layer Va neurons that send axons across the corpus callosum.   
Both scenarios do not obviously account for the observation that the degeneration 
of neurons occurs with a horizontal periodicity, and does not include all of the cells in 
this layer.  This finding implies that the connections of these neurons are specific and that 
the neurons are specifically sensitive to the lesion.   
Both kinds of transcranial stimulation appeared to prevent this additional 
degeneration from occurring, potentially due to the induction of trophic support by the 
tDCS.  This finding does not clarify whether an anterograde or retrograde model of 
transneuronal degeneration (or both) may underlie this extended cell death after lesion. 
To establish a more complete assessment of the layer Va-specific neurodegeneration 
observed in this study future investigations should identify the connectivity of the 
affected neurons by concomitant tract tracing methodologies, and should also better 
identify the mechanisms of cell death in these neurons (e.g., by using terminal 
deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays as well as 
immunohistochemistries for cleaved Caspase3 proteins). 
In addition to elucidating the specific alterations in neuronal connectivity in the 
present study, identifying the phenotypes of the selectively afflicted layer Va neurons is 
likewise necessitated for establishing a pathological basis of neurodegeneration. As of 
yet, the exact phenotype of the degenerating neurons in layer Va is not known. The 
morphology of the FJ-B cells indicates that most of these cells are excitatory pyramidal 
neurons. Within layer Va of the rat cortex there are at least two known anatomically and 
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physiologically distinct pyramidal cell types, intrinsically bursting (IB) and regular 
spiking (RS) cells (Kawaguchi 1993; Kawaguchi & Kubota 1996). Of these pyramidal 
phenotypes, intrinsically bursting (IB) cells are known to produce high-frequency bursts 
of action potentials and exhibit large triangular somata and thick apical dendrites.  IB 
cells receive both intracolumnar excitatory inputs and prominent transcolumnar 
excitatory inputs from neurons located in layers IV, V, and VI of neighboring columns 
(Schubert et al., 2001).  They receive minimal inhibitory input.  Given that IB cells have 
axon that project both horizontally for several millimeters and into the white matter 
(Chagnac-Amitai et al., 1990; Kasperet al., 1994), their extensive participating in the 
coordination of transcolumnar excitatory circuitry of and the minimal inhibitory input 
they receive (Schubert et al., 2001), it is not unreasonable to suspect that the survival of 
IB neurons requires robust input for normal functioning. Conversely, RS neurons are 
distinguished by a smaller, more oval soma, sparser dendritic arborization, a strong 
inhibitory input and more regular discharge patterns (Hefti & Smith, 2000; Schubert et 
al., 2001). The localization of either of these neuronal subtypes within layer V remains 
controversial. Some investigations have claimed IB cells reside in the deepest regions of 
layer IV and Va (Hefti & Smith, 2000) where others refute this position and establish a 
preferential localization of IB cells to layer Vb and a uniform distribution of RS across 
layer Va and Vb (Jacob et al., 2012). Regardless, given their distinct morphological 
features, functional connectivity, and inhibitory control it is thought that IB neurons 
integrate excitatory inputs across cortical columns and thalamic regions whereas RS cells 
seem to be involved in more specific intracolumnar signal processing (Schubert et al., 
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2001).  
It is impossible to determine from the present study which subtype is undergoing 
neurodegeneration after photothrombic stroke. It is possible that this population of dying 
neurons represents a single cell type or a heterogeneous mixture of the IB and RS 
neurons. Further investigation is needed to establish the identity of these neurons. Once 
established, the neuron-specific anatomy and physiology as well as the any known 
underlying circuitry could provide crucial insight into designing future investigations 
aimed at identifying the factors that confer the selective sensitivity to this novel pattern 
neurodegeneration after stroke. 
 
4.3 Major Finding #2: Single-session tDCS does not induce long lasting alteration in 
the functional activity of intracortical networks locally or remotely one day after 
stroke  
Previous work has shown that anodal-tDCS increases neuronal excitability and 
spontaneous firing in both healthy humans and rats (Nitsche & Paulus, 2000; Cambiaghi 
et al., 2010), and reduces local concentrations of the inhibitory neurotransmitter GABA 
(Stagg et al., 2009). Cathodal-tDCS has been shown to have the opposite effects on 
neuronal excitability but reduces local levels of both GABA and glutamate. These effects 
on cortical excitability appear to be long lasting but depend on intensity, duration, and 
frequency of application (Gomez Palacio Schjetnan et al., 2013).  
In the present study, single-session anodal or cathodal tDCS did not appear to 
alter intracortical or transcortical functional activity 1 day after application. A 
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homogenous pattern of c-Fos activation in the lesioned cortex 1 day after anodal-
stimulation in the acute phase of stroke was observed, and is consistent with activation 
patterns produced by cortical spreading depressions and peri-infarct depolarization after 
stroke (Herrera & Robertson, 1990). This comparison suggests that A-tDCS may sustain 
or amplify the propagation of PIDs across the lesion hemisphere well after stroke is 
induced and thus, contribute to the enlargement of the lesion. Follow-up work 
investigating the expression of c-Fos after tDCS application at both earlier and later time 
points after stroke would prove useful in determine the temporal effect of stimulation, if 
any, on neural activity and on the occurrence of PIDs. 
Taken together, the histology of the present study may speak to the inability of 
single-session tDCS to have any sort of long-lasting or widespread effects the functional 
activity of neuronal networks in the acute phase of stroke. Temporal studies investing c-
Fos expression at more immediate time points after stroke and stimulation are needed to 
clarify this point. However, Gass et al. reported a return to low levels of c-Fos expression 
in rats subjected to photothrombic infarction 24 hours after insult. This finding was not 
consistent in the findings of the present study where animals across treatment groups 
demonstrated elevated levels of c-Fos IHC staining 1 day after photothrombic infarction. 
This inconsistency could speak to another known drawbacks of using c-Fos expression as 
a surrogate for neural activity, which is the induction of c-Fos by a variety of 
physiological and environmental stimuli, such as seizures, light, stress, cutaneous 
stimulation, and immobilization (Senba et al., 1993). 
A second major finding from c-Fos IHC revealed that neither single-session of 
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low intensity cathodal tDCS nor anodal tDCS applied in the acute phase of stroke 
significantly altered the functional activity of neurons in the peri-infarct region. Neither 
stimulation polarity appreciably reduced nor expanded the density of c-Fos+ cells in this 
the neuronal populations most at risk of stroke-induced delayed cell death. The lack of 
variably in of the extent of neurodegeneration revealed by FJ-B staining across treatment 
groups supports these conclusion. Interestingly, the localization of c-Fos+ cells in this 
region corresponds with the pattern of neurodegeneration in FJ-B section and therefore it 
is likely that these cell populations overlap indicating that neurons already committed to 
cellular death pathways express c-Fos. Future investigation with fluorescent c-Fos 
immunolabeling in combination with FJ-B staining could confirm this hypothesis as well 
as clarify whether all degenerating neurons or a specific subset in the peri-infarct region 
express c-Fos. Confirmation of c-Fos expression in degeneration neurons confirmed by 
future studies could demonstrate a novel use of c-Fos in marking functional activity of 
dying or mortally-injured neurons after stroke. Though the histology of the peri-lesional 
area is similar to those observed in prior investigations of photothrombic stroke 
experiments, this consistency may demonstrate a limitation of IHC staining for c-Fos. 
Given that tDCS stimulation shares a similar inability with pharmacological 
interventions, such as the NMDA antagonists MK-801, to exert an effect on c-Fos 
expression in the peri-lesional area it is possible that staining is non-specific (Gass et al., 
1992; Kinouchi et al., 1994). Instead the histology in either case could be the result of the 
unmasking of c-Fos-like antigens in the peri-lesional area.  
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4.3 Major Finding #3: Potential layer-specific responses to anodal and cathodal 
stimulation after stroke  
The results of the present study demonstrate that photothrombic lesions cause a 
marked increase in c-Fos immunoreactivity of layer II/III extending horizontally 1 to 2 
mm from the peri-lesional area into the adjacent somatosensory cortex. This consistent 
population of c-Fos immunoreactive neurons did not co-localize with known markers of 
inhibitory neurons or glia cells. Animals that received anodal, but not cathodal 
polarization of the ipsilateral cortex did not exhibit cells with increased c-Fos expression 
in layers III. 
A possible explanation for these observations could be that anodal and cathodal 
polarization may differentially affect post-stimulus neuronal activity in deep vs. 
superficial layers. Monopolar cortical electrical stimulation (CES) of the rat motor cortex 
demonstrated that activity of neurons in the upper cortical layers was increased by after 
cathodic stimulation and decreased after anodic stimulation. The opposite effect was 
reported neuronal activity in the lower cortical layers (Yazdan-Shahmorad et al., 2011). 
The histology of the present study support this layer-specific effect on the functional 
alterations induced by direct current stimulation of the cortex. It is possible that the 
application of anodal tDCS, though lower in spatial specificity than CES, sufficiently 
decreased neuronal activity in layer II/III below suprathreshold levels elicited by cortical 
lesions causing the observed absence of c-Fos activation. Likewise, the presence of c-Fos 
expression in layer II/III in animals that received cathodal stimulation support the 
functional data that cathodal direct current stimulation increases functional activity in the 
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upper layers of the cortex.   
Moreover, given that not all neurons of layer II/III expressed c-Fos in this region, 
it is possible that on top of layer specific effects, perhaps subpopulations of neurons 
within layers exhibit differential sensitivities to the alterations in network activity caused 
by photothrombic stroke and tDCS in a polarity-specific manner. The observation that the 
c-Fos expressing neurons in layer II/III did not co-stain with markers of inhibitory 
neurons, demonstrates that these neurons are excitatory in nature.  Moreover, this finding 
is consistent with the idea that different subpopulations of neurons are not equally 
effected by stroke and tDCS. However, future work that more precisely identifies these 
activated layer II/III neuron subtypes is needed in order to fully understand these layer-
specific alterations of neuronal activity elicited by stimulation with opposing tDCS 
polarities.  
The increase in c-Fos expression in layer III may represent an activated 
intracortical network that elicits sustained suprathreshold activity in specific neuronal 
populations adjacent to the lesion. FJ-B stained indicated that these neurons were not 
degenerating 1 day after stroke. Consistent with the functional alterations observed by 
Schiene et al. in associated barrel fields 1 week after stroke, the histology observed at 
present may reveal a subpopulation of neurons involved in the more immediate activities 
of functional reorganization in the lesioned cortex that disinhibition is suspected to 
mediate (Schiene et al., 1999). Furthermore, the finding that the activity of layer II/III 
neuron may be differentially affected by tDCS could provide a basis for the invention’s 
ability to modulate functional reorganization after stroke. However, the discovery of 
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layer V pyramidal neurodegeneration by Fluoro-Jade B staining in these same regions 
indicates that lesion induced changes to network activity are exclusively functional in 
nature and not the result, at least in part, of cytoarchitonic alterations. It is possible that 
functional alterations in excitatory connections and disinhibitory networks observed at 
later time points after stroke coincide with earlier changes in local activity and 
cytoarchitecture. 
 
4.5 Major Finding #4: Immunohistochemistry evidence does not yet provide 
histological basis of interneuron involvement in diaschisis 
One of the goals of the current study was establish a cellular basis of diaschsis 
after stroke. Specifically, identifying possible interneuron participation in the evolution 
disinhibition in acute phase of stroke was sought after to support evidence of the 
mechanism by which focal ischemia produced changes in activity in the ipsilateral and 
contralateral hemisphere. A novel approach using known markers of neuronal activity, 
distinct interneuron cell types, and neurodegeneration was undertaken to accomplish this 
goal. 
Prior investigations in to a disinhibitory model of diaschisis demonstrated that 
photothrombic infarction increased neuronal excitability in layers II/III, expanded 
vibrissa representation and induced long-lasting reductions of GABAA receptor 
expression in the cortical areas surrounding the lesion (Schiene et al., 1996; Schiene et 
al., 1999). These findings currently cited as supporting evidence to the disinhibitory 
model of functional alterations in remote areas of the brain after stroke. The current study 
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sought out to expand on this body of evidence by providing a robust histological basis for 
disinhibition after stroke but failed to do so. Inhibitory interneurons stained the non-
overlapping markers of vasoactive intestinal peptide (VIP) and parvalbumin (parv) as 
well as the calcium binding protein, calretinin (CR), which is known to localize with parv 
expressing interneurons, were not found to co-stain with c-Fos expressing neurons in any 
consistent or obvious way after stroke. Identical observations were made even with 
cortical stimulation, a technique known to modulate neuronal activity. Thus, interneuron 
functional activity, specifically VIP expressing interneurons that are known to mediate 
disinhibition in the cortex, was not found to be altered in any histologically appreciable 
manner 1 day after stroke. 
 
4.6 Major Finding #5: Single-session tDCS does demonstrate a polarity-specific 
neuroprotective or neuropathological effect on the brain but it is not statistically 
significant 
Recent investigations in rodent models have demonstrated that tDCS applied in 
the acute phase of stroke cab exert either neuroprotective or neuropathological effects on 
the brain. Specifically, Peruzzotti-Jametti et al. established a measurable neuroprotective 
effect of cathodal tDCS applied in the acute phase of stroke in mice regarding the 
preservation of cortical neurons from the ischemic damage, the reduction of 
inflammation, and promotion of a better clinical recovery. Conversely, anodal stimulation 
induces an increase in post-ischemic lesion sizes and amplified blood brain barrier 
dysfunction (Peruzzotti-Jametti et al., 2013). Following up on that study in a rat model, 
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Notturno et al. showed that cathodal stimulation reduced infarct volumes accompanied by 
a reduction in peri-infarct depolarizations. Employing a novel paradigm of cathodal and 
anodal stimulation in the acute phase of stroke in rats, the present study demonstrate 
similar findings regarding the polarity-specific neuroprotective and neuropathological 
roles of tDCS, but the effects were not found to be statistically significant.  In the present 
study, single-session cathodal tDCS did demonstrate a reduction in average lesion 
volume or brain swelling but these effects were not found to be significant when 
compared to animals that did not receive stimulation. Correspondingly, single-session 
anodal tDCS demonstrated average increases in lesion volumes and brain swelling but 
again, the measures of either failed to be significant when compared to non-stimulated 
animals. Furthermore, the histology demonstrates neither anodal cathodal tDCS failed to 
demonstrate any observable attenuation or exacerbation of the neuropathological 
response elicited by reactive astrocytes under immunohistochemical staining. Although 
the effects of single-session tDCS paradigms were not found to be statistically significant 
across treatment groups, it is thought that larger sample sizes would confer a higher 
statistical power needed to demonstrate statistical significance. 
 
4.7 Methodical considerations 
Several factors regarding the methodologies and parameters of tDCS application 
under this stimulation paradigm could explain the negative findings of the study. First, it 
is well established that the stimulation parameters of tDCS play a critical role in 
determining its effect on the brain. Previous work with tDCS has demonstrated that 
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placement of both the stimulating and reference electrodes determines, at least in part, the 
spatial distribution and direction of the flow of current which in turn may determine the 
effectiveness of current (Gomez Palacio Schjetnan et al., 2013). Miranda et al. showed 
that as distance between the two electrodes increase, the current flow into the brain as 
well as the depth of current density are both enhanced (Miranda et al., 2006). In this 
study, the midline of the dorsal thorax was selected as the location for the reference 
electrode whereas the ventral thorax was the selected location of the reference electrode 
in the studies conducted by Peruzzotti-Jametti et al. and Notturno et al. (Peruzzotti-
Jametti et al., 2013; Notturno et al., 2014). Given the location of the reference electrode 
in this study it is possible that current was shunted across the surface of the brain and 
cranium rather through cortical tissue, as is most likely the case when the electrode is 
placed on the ventral thorax.  
Second, it is possible that the physical composition and dimensions of the 
electrodes themselves reduced the effectiveness of stimulation. It is widely accepted that 
surface area of the electrodes has been shown to determine outcome of transcranial 
stimulation (Gomez Palacio Schjetnan et al., 2013). In the present study, the stimulating 
and reference electrodes were identical in size (25 mm2), rectangular in shape, and 
composed of a carbon conductor and pictographic storage liner. Most often electrodes are 
circular in shape to avoid current density points, and the stimulating and reference 
electrodes differed considerably in size with the return electrode being at least an order of 
magnitude larger than the stimulating electrode. In light of these differences, the finding 
that decreasing the size of the stimulating electrode relative to the size of the reference 
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electrode allows for more focal treatment effects in the human motor cortex (Nitsche et 
al., 2007) is of particular interest. In light of the crucial role that the physical design and 
dimension of electrodes, it is probable that the current study’s stimulation paradigms 
more broadly affected the brain rather than having a targeted effect on the site of the 
evolving lesion. However, in the present study a broad effect was desired as the 
stimulation was intended to modulate the activity of neuronal populations distant from 
the site of lesion. 
Another prominent point of divergence from previous studies’ tDCS parameters is 
the timing and duration of stimulation. In addition to current intensity, it has been widely 
reported that the prolonged after effects of tDCS in the human motor cortex, such as 
restoring equilibrium in disrupted network, improving structural plasticity, and improving 
functional recovery, depend, at least in part, on the frequency and duration of tDCS 
application (Nitsche & Paulus, 2000; Nitsche & Paulus, 2001; Nitsche et al., 2003; 
Adkins-Muir & Jones, 2003; Teskey et al., 2003).  In the present study, low intensity 
current (8 mA/cm2) was employed for a single session of approximately 5 minutes in the 
acute phase of stroke. The previous studies by Peruzzotti-Jametti et al. and Notturno et al. 
used similar current intensities, but delivered current in a repetitive fashion of on-off-on 
stimulation cycles that resulted in a cumulative stimulation duration from 40 minutes up 
to 180 minutes (Peruzzotti-Jametti et al., 2013; Notturno et al., 2014).  These studies have 
current density below the limit for damage, however, likely to exert total charge density 
3–4 times higher than that observed to produce lesions (170–200kC/m2 (calculated from 
Peruzzotti-Jametti et al., 2013; Notturno et al., 2014) vs. 52kC/m2 (limit); Liebetanz et 
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al., 2000).  Even so, since the previously cited studies showed a beneficial effect of such 
high total charge densities, perhaps the lesion itself adjusts the dosing of the tDCS and 
protects the neurons instead of inducing further damage. 
Finally, the administration duration of isoflurane, a commonly used volatile 
anesthetic with known neuroprotective effects, may have attenuated the 
neuropathological effects of ischemia in the models to which the current study is being 
compared. The use of isoflurane as an anesthetic in rat models of MCAO has been shown 
to reduce both infarct size and neurologic deficit independent of ischemia duration, 
perfusion pressure (Sakai et al. 2007). Moreover, Xiong et al. demonstrated that repeated 
precondition with isoflurane for five days prior to focal ischemia in rats induces ischemic 
tolerance in a dose-dependent manner (Xiong et al., 2003).  Peruzzotti-Jametti et al. 
anesthetized mice with isoflurane while installing the epicranial electrodes five days prior 
to MCAO and thus, may have introduced ischemic tolerance that is not accounted for by 
the study. The rats in the investigation conducted by Notturno et al. were maintained 
under 2% isoflurane for 8 to 9 hours, an anesthetic dose that is considerable longer than 
the current study which was at most 116 minutes. Taking into account the precondition 
and dose-dependent ischemic tolerance conferred by isoflurane, it is possible that 
neuroprotective effects of cathodal-tDCS applied in the acute phase of stroke established 
by previous investigations may be exaggerated.  
Coupled with low sample sizes, it is reasonable to conclude that the deviation in 
this study’s stimulation parameters and methodologies from those previously established 
are sufficient enough to push neuroprotective or neuropathological role tDCS exerts on 
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the ischemic brain above a statistically significant level. Likewise, it is possible that the 
neuroprotective effects of C-tDCS applied acutely after stroke reported by prior 
investigations may be overstated when compared to the current study. Moving forward in 
light of these considerations, it would be advantageous to optimize and standardize the 
parameters and methodologies of tDCS administration in order to maximize its 
effectiveness prior to translating the findings of animal models to clinical applications of 
acute tDCS stroke therapies. It is of paramount importance to establish the optimal tDCS 
parameters current intensity, duration, and frequency of stimulation in addition to 
improving electrode design and placement as the current study in conjunction with prior 
work demonstrate the critical role these factors play in influencing the therapy’s 
neuropathological and neurophysiological effects following stroke.  
 
4.8 Conclusions 
The findings of this study help to further the understanding of a neuroanatomical 
basis for the electrical imbalance in the brain after stroke as well as the modulatory 
effects of transcranial direct current stimulation on neuronal network activity. It was 
found that unilateral ischemic injury does not produce a hyperexcitability of the 
contralateral cortex or otherwise alter the activation status of immunohistochemcially-
defined inhibitory or disinhibitory neurons, a finding inconsistent with the reasoning used 
to treat ischemic brain injury in humans. Cathodal and anodal stimulation also did not 
obviously alter the activation status of inhibitory or disinhibitory neurons.  Ischemia 
activated white matter neurons, as well as neurons in layer III ipsilateral to the lesion 
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extending 1–2mm into the intact cortex were also observed. Anodal tDCS, but not 
cathodal tDCS, reduced the activation of excitatory layer III neurons. Transneuronal 
degeneration was discovered in clusters of pyramidal-shape neurons of layer V neurons 
extending to remote, but intact regions of the ipsilateral somatosensory regions.  
Application of cathodal tDCS, but not anodal tDCS, was predictive in reducing lesion 
size and brain swelling although these size decreases were not statistically reliable.  
Stimulation of both types prevented the appearance of cell death markers in layer V.  
Overall, these findings illustrate the efficacy of using tDCS during the production 
of a lesion to mitigating the size and impact of lesion when applied in the acute phase of 
stroke. However, the data do not support the rationale for applying brain stimulation to 
the contralesional cortex to treat stroke, at least in the acute stage.  Finally, the data 
highlights the widespread and specific neural circuits effected by stroke, and highlights 
the potential therapeutic power tDCS has in manipulating the activity of these circuits. 
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